Methods, compositions, and kits comprising linker probes for quantifying polynucleotides

[0001] This application is a Divisional Application of U.S. Non-Provisional application Ser. No. 10/947,460, filed Sep. 21, 2004, which itself claims priority to U.S. Provisional Application 60/575,661, filed May 28, 2005, U.S. Provisional Application 60/612,216, filed Sep. 21, 2004, and U.S. Provisional Application 60/643,810, filed Jan. 14, 2005. This application is co-filed with U.S. Provisional Application Linear Amplification of Short Nucleic Acids to Bloch, U.S. Provisional Patent Application Method for Identifying Medically Important Cell Populations Using Micro RNA as Tissue Specific Biomarkers to Bloch, Karger, Straus, Lau, and Chen, and U.S. Provisional Patent Application Methods for Characterizing Cells Using Amplified Micro RNAs, to Lao, Straus, Nan Xu, Bloch, and Chen.

[0002] The present teachings are in the field of molecular and cell biology, specifically in the field of detecting target polynucleotides such as miRNA.

[0003] RNA interference (RNAi) is a highly coordinated, sequence-specific mechanism involved in posttranscriptional gene regulation. During the initial steps of process, a ribonuclease (RNase) II-like enzyme called Dicer reduces long double-strand RNA (dsRNA) and complex hairpin precursors into: 1) small interfering RNAs (siRNA) that degrade messenger RNA (mRNA) and 2) micro RNAs (miRNAs) that can target mRNAs for cleavage or attenuate translation.

[0004] The siRNA class of molecules is thought to be comprised of 21-23 nucleotide (nt) depluxes with characteristic dinucleotide 3′ overhangs (Ambros et al., 2003, RNA, 9 (3), 277-279). siRNA has been shown to act as the functional intermediate in RNAi, specifically directing cleavage of complementary mRNA targets in a process that is commonly regarded to be an antiviral cellular defense mechanism (Elbashir et al., 2001, Nature, 411:6836), 494-498, Elbashir et al., 2001, Genes and Development, 15 (2), 188-200). Target RNA cleavage is catalyzed by the RNA-induced silencing complex (RISC), which functions as a siRNA directed endonuclease (reviewed in Bartel, 2004, Cell, 116 (2), 281-297).

[0005] Micro RNAs (miRNAs) typically comprise single-stranded, endogenous oligoribonucleotides of roughly 22 (18-25) bases in length that are processed from larger stem-looped precursor RNAs. The first genes recognized to encode miRNAs, lin-4 and let-7 of C. elegans, were identified on the basis of the developmental timing defects associated with the loss-of-function mutations (Lee et al., 1993, Cell, 75 (5), 843-854; Reinhart et al., 2000, Nature, 403, (6772), 901-906; reviewed by Pasquinelli et al., 2002, Annual Review of Cell and Developmental Biology, 18, 495-513). The breadth and importance of miRNA-directed gene regulation are coming into focus as more miRNAs and regulatory targets and functions are discovered. To date, a total of at least 700 miRNAs have been identified in C. elegans, Drosophila (Fire et al., 1998, Nature, 391 (6669(, 805-811), mouse, human (Lagos-Quintana et al., 2001, Science, 294 (5543), 853-858), and plants (Reinhart et al., 2002, Genes and Development, 16 (13), 1616-1626). Their sequences are typically conserved among different species. Size ranges from 18 to 25 nucleotides for miRNAs are the most commonly observed to date.

[0006] The function of most miRNAs is not known. Recently discovered miRNA functions include control of cell proliferation, cell death, and fat metabolism in flies (Brennecke et al., 2003, cell, 113 (1), 25-36; Xu et al, 2003, Current Biology, 13 (9), 790-795), neuronal patterning in nematodes (Johnston and Hobert, 2003, Nature, 426 (6968), 845-849), modulation of hematopoietic lineage differentiation in mammals (Chen et al., 2004, Science, 303 (5654), 83-87), and control of leaf and flower development in plants (Aukerman and Sakai, 2003, Plant Cell, 15 (11), 2730-2741; Chen, 2003, Science, 303 (5666):2022-2025; Emery et al., 2003, Current Biology, 13 (20), 1768-1774; Palatnik et al., 2003, Nature, 425 (6955), 257-263). There is speculation that miRNAs may represent a new aspect of gene regulation.

[0007] Most miRNAs have been discovered by cloning. There are few cloning kits available for researchers from Ambion and QIAGEN etc. The process is laborious and less accurate. Further, there has been little reliable technology available for miRNA quantitation (Allawi et al., Third Wave Technologies, RNA. 2004 July;10(7):1153-61). Northern blotting has been used but results are not quantitative (Lagos-Quitana et al., 2001, Science, 294 (5543), 853-854). Many miRNA researchers are interested in monitoring the level of the miRNAs at different tissues, at the different stages of development, or after treatment with various chemical agents. However, the short length of miRNAs has their study difficult.

[0008] In some embodiments, the present teachings provide a method for detecting a micro RNA (miRNA) comprising; hybridizing the miRNA and a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target-specific portion, wherein the 3′ target-specific portion base pairs with the 3′ end region of the miRNA; extending the linker probe to form an extension reaction product; amplifying the extension reaction product to form an amplification product; and, detecting the miRNA.

[0009] In some embodiments, the present teachings provide a method for detecting a target polynucleotide comprising; hybridizing the target polynucleotide and a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target-specific portion, wherein the 3′ target-specific portion base pairs with the 3′ end region of the target polynucleotide; extending the linker probe to form an extension reaction product; amplifying the extension reaction product to form an amplification product in the presence of a detector probe, wherein the detector probe comprises a nucleotide of the linker probe stem in the amplification product or a nucleotide of the linker probe stem complement in the amplification product; and, detecting the target polynucleotide.

[0010] In some embodiments, the present teachings provide a method for detecting a miRNA molecule comprising; hybridizing the miRNA molecule and a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target specific portion, wherein the 3′ target-specific portion base pairs with the 3′ end region of the target polynucleotide; extending the linker probe to form an extension reaction product; amplifying the extension reaction product in the presence of a detector probe to form an amplification product, wherein the detector probe comprises a nucleotide of the linker probe stem in the amplification product or a nucleotide of the linker probe stem complement in the amplification product, and the detector probe further comprises a nucleotide of the 3′ end region of the miRNA in the amplification product or a nucleotide of the 3′ end region of the miRNA complement in the amplification product; and, detecting the miRNA molecule.

[0011] In some embodiments, the present teachings provide a method for detecting two different miRNAs from a single hybridization reaction comprising; hybridizing a first miRNA and a first linker probe, and a second miRNA and a second linker probe, wherein the first linker probe and the second linker probe each comprise a loop, a stem, and a 3′ target-specific portion, wherein the 3′ target-specific portion of the first linker probe base pairs with the 3′ end region of the first miRNA, and wherein the 3′ target-specific portion of the second linker probe base pairs with the 3′ end region of the second miRNA; extending the first linker probe and the second linker probe to form extension reaction products; dividing the extension reaction products into a first amplification reaction to form a first amplification reaction product, and a second amplification reaction to form a second amplification reaction product, wherein a primer in the first amplification reaction corresponds with the first miRNA and not the second miRNA, and a primer in the second amplification reaction corresponds with the second miRNA and not the first miRNA, wherein a first detector probe in the first amplification reaction differs from a second detector probe in the second amplification reaction, wherein the first detector probe comprises a nucleotide of the first linker probe stem of the amplification product or a nucleotide of the first linker probe stem complement in the first amplification product, wherein the second detector probe comprises a nucleotide of the second linker probe stem of the amplification product or a nucleotide of the second linker probe stem complement in the amplification product; and, detecting the two different miRNAs.

[0012] In some embodiments, the present teachings provide a method for detecting two different target polynucleotides from a single hybridization reaction comprising; hybridizing a first target polynucleotide and a first linker probe, and a second target polynucleotide and a second linker probe, wherein the first linker probe and the second linker probe each comprise a loop, a stem, and a 3′ target-specific portion, wherein the 3′ target-specific portion of the first linker probe base pairs with the 3′ end region of the first target polynucleotide, and wherein the 3′ target-specific portion of the second linker probe base pairs with the 3′ end region of the second target polynucleotide; extending the first linker probe and the second linker probe to form extension reaction products; dividing the extension reaction products into a first amplification reaction to form a first amplification reaction product and a second amplification reaction to form a second amplification reaction product; and, detecting the two different miRNA molecules.

[0013] In some embodiments, the present teachings provide a method for detecting a miRNA molecule from a cell lysate comprising; hybridizing the miRNA molecule from the cell lysate with a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target specific portion, wherein the 3′ target-specific portion base pairs with the 3′ end region of the miRNA; extending the linker probe to form an extension reaction product; amplifying the extension reaction product to form an amplification product in the presence of a detector probe, wherein the detector probe comprises a nucleotide of the linker probe stem of the amplification product or a nucleotide of the linker probe stem complement in the amplification product, and the detector probe further comprises a nucleotide of the 3′ end region of the miRNA in the amplification product or a nucleotide of the 3′ end region of the miRNA complement in the amplification product; and, detecting the miRNA molecule.

[0014] A kit comprising; a reverse transcriptase and a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target-specific portion, wherein the 3′ target-specific portion corresponds to a miRNA.

[0015] The present teachings contemplate method for detecting a miRNA molecule comprising a step of hybridizing, a step of extending, a step of amplifying, and a step of detecting.

[0016] These and other features of the present teachings are set forth herein.

[0024] Aspects of the present teachings may be further understood in light of the following examples, which should not be construed as limiting the scope of the present teachings in any way. The section headings used herein are for organizational purposes only and are not to be construed as limiting the described subject matter in any way. All literature and similar materials cited in this application, including but not limited to, patents, patent applications, articles, books, treatises, and internet web pages are expressly incorporated by reference in their entirety for any purpose. When definitions of terms in incorporated references appear to differ from the definitions provided in the present teachings, the definition provided in the present teachings shall control. It will be appreciated that there is an implied “about” prior to the temperatures, concentrations, times, etc discussed in the present teachings, such that slight and insubstantial deviations are within the scope of the present teachings herein. In this application, the use of the singular includes the plural unless specifically stated otherwise. For example, “a primer” means that more than one primer can, but need not, be present; for example but without limitation, one or more copies of a particular primer species, as well as one or more versions of a particular primer type, for example but not limited to, a multiplicity of different forward primers. Also, the use of “comprise”, “comprises”, “comprising”, “contain”, “contains”, “containing”, “include”, “includes”, and “including” are not intended to be limiting. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention.

Some Definitions

[0025] As used herein, the term “target polynucleotide” refers to a polynucleotide sequence that is sought to be detected. The target polynucleotide can be obtained from any source, and can comprise any number of different compositional components. For example, the target can be nucleic acid (e.g. DNA or RNA), transfer RNA, siRNA, and can comprise nucleic acid analogs or other nucleic acid mimic. The target can be methylated, non-methylated, or both. The target can be bisulfite-treated and non-methylated cytosines converted to uracil. Further, it will be appreciated that “target polynucleotide” can refer to the target polynucleotide itself, as well as surrogates thereof, for example amplification products, and native sequences. In some embodiments, the target polynucleotide is a miRNA molecule. In some embodiments, the target polynucleotide lacks a poly-A tail. In some embodiments, the target polynucleotide is a short DNA molecule derived from a degraded source, such as can be found in for example but not limited to forensics samples (see for example Butler, 2001, Forensic DNA Typing: Biology and Technology Behind STR Markers. The target polynucleotides of the present teachings can be derived from any of a number of sources, including without limitation, viruses, prokaryotes, eukaryotes, for example but not limited to plants, fungi, and animals. These sources may include, but are not limited to, whole blood, a tissue biopsy, lymph, bone marrow, amniotic fluid, hair, skin, semen, biowarfare agents, anal secretions, vaginal secretions, perspiration, saliva, buccal swabs, various environmental samples (for example, agricultural, water, and soil), research samples generally, purified samples generally, cultured cells, and lysed cells. It will be appreciated that target polynucleotides can be isolated from samples using any of a variety of procedures known in the art, for example the Applied Biosystems ABI Prism™ 6100 Nucleic Acid PrepStation, and the ABI Prism™ 6700 Automated Nucleic Acid Workstation, Boom et al., U.S. Pat. No. 5,234,809., mirVana RNA isolation kit (Ambion), etc. It will be appreciated that target polynucleotides can be cut or sheared prior to analysis, including the use of such procedures as mechanical force, sonication, restriction endonuclease cleavage, or any method known in the art. In general, the target polynucleotides of the present teachings will be single stranded, though in some embodiments the target polynucleotide can be double stranded, and a single strand can result from denaturation.

[0026] As used herein, the term “3′ end region of the target polynucleotide” refers to the region of the target to which the 3′ target specific portion of the linker probe hybridizes. In some embodiments there can be a gap between the 3′ end region of the target polynucleotide and the 5′ end of the linker probe, with extension reactions filling in the gap, though generally such scenarios are not preferred because of the likely destabilizing effects on the duplex. In some embodiments, a miRNA molecule is the target, in which case the term “3′ end region of the miRNA” is used.

[0027] As used herein, the term “linker probe” refers to a molecule comprising a 3′ target specific portion, a stem, and a loop. Illustrative linker probes are depicted in FIG. 2 and elsewhere in the present teachings. It will be appreciated that the linker probes, as well as the primers of the present teachings, can be comprised of ribonucleotides, deoxynucleotides, modified ribonucleotides, modified deoxyribonucleotides, modified phosphate-sugar-backbone oligonucleotides, nucleotide analogs, or combinations thereof. For some illustrative teachings of various nucleotide analogs etc, see Fasman, 1989, Practical Handbook of Biochemistry and Molecular Biology, pp. 385-394, CRC Press, Boca Raton, Fla., Loakes, N.A.R. 2001, vol 29:2437-2447, and Pellestor et al., Int J Mol Med. 2004 April; 13(4):521-5.), references cited therein, and recent articles citing these reviews. It will be appreciated that the selection of the linker probes to query a given target polynucleotide sequence, and the selection of which collection of target polynucleotide sequences to query in a given reaction with which collection of linker probes, will involve procedures generally known in the art, and can involve the use of algorithms to select for those sequences with minimal secondary and tertiary structure, those targets with minimal sequence redundancy with other regions of the genome, those target regions with desirable thermodynamic characteristics, and other parameters desirable for the context at hand.

[0028] As used herein, the term “3′ target-specific portion” refers to the single stranded portion of a linker probe that is complementary to a target polynucleotide. The 3′ target-specific portion is located downstream from the stem of the linker probe. Generally, the 3′ target-specific portion is between 6 and 8 nucleotides long. In some embodiments, the 3′ target-specific portion is 7 nucleotides long. It will be appreciated that routine experimentation can produce other lengths, and that 3′ target-specific portions that are longer than 8 nucleotides or shorter than 6 nucleotides are also contemplated by the present teachings. Generally, the 3′-most nucleotides of the 3′ target-specific portion should have minimal complementarity overlap, or no overlap at all, with the 3′ nucleotides of the forward primer; it will be appreciated that overlap in these regions can produce undesired primer dimer amplification products in subsequent amplification reactions. In some embodiments, the overlap between the 3′-most nucleotides of the 3′ target-specific portion and the 3′ nucleotides of the forward primer is 0, 1, 2, or 3 nucleotides. In some embodiments, greater than 3 nucleotides can be complementary between the 3′-most nucleotides of the 3′ target-specific portion and the 3′ nucleotides of the forward primer, but generally such scenarios will be accompanied by additional non-complementary nucleotides interspersed therein. In some embodiments, modified bases such as LNA can be used in the 3′ target specific portion to increase the Tm of the linker probe (see for example Petersen et al., Trends in Biochemistry (2003), 21:2:74-81). In some embodiments, universal bases can be used, for example to allow for smaller libraries of linker probes. Universal bases can also be used in the 3′ target specific portion to allow for the detection of unknown targets. For some descriptions of universal bases, see for example Loakes et al., Nucleic Acids Research, 2001, Volume 29, No. 12, 2437-2447. In some embodiments, modifications including but not limited to LNAs and universal bases can improve reverse transcription specificity and potentially enhance detection specificity.

[0029] As used herein, the term “stem” refers to the double stranded region of the linker probe that is between the 3′ target-specific portion and the loop. Generally, the stem is between 6 and 20 nucleotides long (that is, 6-20 complementary pairs of nucleotides, for a total of 12-40 distinct nucleotides). In some embodiments, the stem is 8-14 nucleotides long. As a general matter, in those embodiments in which a portion of the detector probe is encoded in the stem, the stem can be longer. In those embodiments in which a portion of the detector probe is not encoded in the stem, the stem can be shorter. Those in the art will appreciate that stems shorter that 6 nucleotides and longer than 20 nucleotides can be identified in the course of routine methodology and without undue experimentation, and that such shorter and longer stems are contemplated by the present teachings. In some embodiments, the stem can comprise an identifying portion.

[0030] As used herein, the term “loop” refers to a region of the linker probe that is located between the two complementary strands of the stem, as depicted in FIG. 1 and elsewhere in the present teachings. Typically, the loop comprises single stranded nucleotides, though other moieties modified DNA or RNA, Carbon spacers such as C18, and/or PEG (polyethylene glycol) are also possible. Generally, the loop is between 4 and 20 nucleotides long. In some embodiments, the loop is between 14 and 18 nucleotides long. In some embodiments, the loop is 16 nucleotides long. As a general matter, in those embodiments in which a reverse primer is encoded in the loop, the loop can generally be longer. In those embodiments in which the reverse primer corresponds to both the target polynucleotide as well as the loop, the loop can generally be shorter. Those in the art will appreciate that loops shorter that 4 nucleotides and longer than 20 nucleotides can be identified in the course of routine methodology and without undue experimentation, and that such shorter and longer loops are contemplated by the present teachings. In some embodiments, the loop can comprise an identifying portion.

[0031] As used herein, the term “identifying portion” refers to a moiety or moieties that can be used to identify a particular linker probe species, and as a result determine a target polynucleotide sequence, and can refer to a variety of distinguishable moieties including zipcodes, a known number of nucleobases, and combinations thereof. In some embodiments, an identifying portion, or an identifying portion complement, can hybridize to a detector probe, thereby allowing detection of a target polynucleotide sequence in a decoding reaction. The terms “identifying portion complement” typically refers to at least one oligonucleotide that comprises at least one sequence of nucleobases that are at least substantially complementary to and hybridize with their corresponding identifying portion. In some embodiments, identifying portion complements serve as capture moieties for attaching at least one identifier portion:element complex to at least one substrate; serve as “pull-out” sequences for bulk separation procedures; or both as capture moieties and as pull-out sequences (see for example O'Neil, et al., U.S. Pat. Nos. 6,638,760, 6,514,699, 6,146,511, and 6,124,092). Typically, identifying portions and their corresponding identifying portion complements are selected to minimize: internal, self-hybridization; cross-hybridization with different identifying portion species, nucleotide sequences in a reaction composition, including but not limited to gDNA, different species of identifying portion complements, or target-specific portions of probes, and the like; but should be amenable to facile hybridization between the identifying portion and its corresponding identifying portion complement. Identifying portion sequences and identifying portion complement sequences can be selected by any suitable method, for example but not limited to, computer algorithms such as described in PCT Publication Nos. WO 96/12014 and WO 96/41011 and in European Publication No. EP 799,897; and the algorithm and parameters of SantaLucia (Proc. Natl. Acad. Sci. 95:1460-65 (1998)). Descriptions of identifying portions can be found in, among other places, U.S. Pat. No. 6,309,829 (referred to as “tag segment” therein); U.S. Pat. No. 6,451,525 (referred to as “tag segment” therein); U.S. Pat. No. 6,309,829 (referred to as “tag segment” therein); U.S. Pat. No. 5,981,176 (referred to as “grid oligonucleotides” therein); U.S. Pat. No. 5,935,793 (referred to as “identifier tags” therein); and PCT Publication No. WO 01/92579 (referred to as “addressable support-specific sequences” therein). In some embodiments, the stem of the linker probe, the loop of the linker probe, or combinations thereof can comprise an identifying portion, and the detector probe can hybridize to the corresponding identifying portion. In some embodiments, the detector probe can hybridize to both the identifying portion as well as sequence corresponding to the target polynucleotide. In some embodiments, at least two identifying portion: identifying portion complement duplexes have melting temperatures that fall within a ΔT_m range (T_max−T_min) of no more than 10° C. of each other. In some embodiments, at least two identifying portion: identifying portion complement duplexes have melting temperatures that fall within a ΔT_m range of 5° C. or less of each other. In some embodiments, at least two identifying portion: identifying portion complement duplexes have melting temperatures that fall within a ΔT_m range of 2° C. or less of each other. In some embodiments, at least one identifying portion or at least one identifying portion complement is used to separate the element to which it is bound from at least one component of a ligation reaction composition, a digestion reaction composition, an amplified ligation reaction composition, or the like. In some embodiments, identifying portions are used to attach at least one ligation product, at least one ligation product surrogate, or combinations thereof, to at least one substrate. In some embodiments, at least one ligation product, at least one ligation product surrogate, or combinations thereof, comprise the same identifying portion. Examples of separation approaches include but are not limited to, separating a multiplicity of different element: identifying portion species using the same identifying portion complement, tethering a multiplicity of different element: identifying portion species to a substrate comprising the same identifying portion complement, or both. In some embodiments, at least one identifying portion complement comprises at least one label, at least one mobility modifier, at least one label binding portion, or combinations thereof. In some embodiments, at least one identifying portion complement is annealed to at least one corresponding identifying portion and, subsequently, at least part of that identifying portion complement is released and detected, see for example Published P.C.T. Application WO04/4634 to Rosenblum et al., and Published P.C.T. Application WO01/92579 to Wenz et al.,

[0032] As used herein, the term “extension reaction” refers to an elongation reaction in which the 3′ target specific portion of a linker probe is extended to form an extension reaction product comprising a strand complementary to the target polynucleotide. In some embodiments, the target polynucleotide is a miRNA molecule and the extension reaction is a reverse transcription reaction comprising a reverse transcriptase. In some embodiments, the extension reaction is a reverse transcription reaction comprising a polymerase derived from a Eubacteria. In some embodiments, the extension reaction can comprise rTth polymerase, for example as commercially available from Applied Biosystems catalog number N808-0192, and N808-0098. In some embodiments, the target polynucleotide is a miRNA or other RNA molecule, and as such it will be appreciated that the use of polymerases that also comprise reverse transcription properties can allow for some embodiments of the present teachings to comprise a first reverse transcription reaction followed thereafter by an amplification reaction, thereby allowing for the consolidation of two reactions in essentially a single reaction. In some embodiments, the target polynucleotide is a short DNA molecule and the extension reaction comprises a polymerase and results in the synthesis of a 2^nd strand of DNA. In some embodiments, the consolidation of the extension reaction and a subsequent amplification reaction is further contemplated by the present teachings.

[0033] As used herein, the term “primer portion” refers to a region of a polynucleotide sequence that can serve directly, or by virtue of its complement, as the template upon which a primer can anneal for any of a variety of primer nucleotide extension reactions known in the art (for example, PCR). It will be appreciated by those of skill in the art that when two primer portions are present on a single polynucleotide, the orientation of the two primer portions is generally different. For example, one PCR primer can directly hybridize to a first primer portion, while the other PCR primer can hybridize to the complement of the second primer portion. In addition, “universal” primers and primer portions as used herein are generally chosen to be as unique as possible given the particular assays and host genomes to ensure specificity of the assay.

[0034] As used herein, the term “forward primer” refers to a primer that comprises an extension reaction product portion and a tail portion. The extension reaction product portion of the forward primer hybridizes to the extension reaction product. Generally, the extension reaction product portion of the forward primer is between 9 and 19 nucleotides in length. In some embodiments, the extension reaction product portion of the forward primer is 16 nucleotides. The tail portion is located upstream from the extension reaction product portion, and is not complementary with the extension reaction product; after a round of amplification however, the tail portion can hybridize to complementary sequence of amplification products. Generally, the tail portion of the forward primer is between 5-8 nucleotides long. In some embodiments, the tail portion of the forward primer is 6 nucleotides long. Those in the art will appreciate that forward primer tail portion lengths shorter than 5 nucleotides and longer than 8 nucleotides can be identified in the course of routine methodology and without undue experimentation, and that such shorter and longer forward primer tail portion lengths are contemplated by the present teachings. Further, those in the art will appreciate that lengths of the extension reaction product portion of the forward primer shorter than 9 nucleotides in length and longer than 19 nucleotides in length can be identified in the course of routine methodology and without undue experimentation, and that such shorter and longer extension reaction product portion of forward primers are contemplated by the present teachings.

[0035] As used herein, the term “reverse primer” refers to a primer that when extended forms a strand complementary to the target polynucleotide. In some embodiments, the reverse primer corresponds with a region of the loop of the linker probe. Following the extension reaction, the forward primer can be extended to form a second strand product. The reverse primer hybridizes with this second strand product, and can be extended to continue the amplification reaction. In some embodiments, the reverse primer corresponds with a region of the loop of the linker probe, a region of the stem of the linker probe, a region of the target polynucleotide, or combinations thereof. Generally, the reverse primer is between 13-16 nucleotides long. In some embodiments the reverse primer is 14 nucleotides long. In some embodiments, the reverse primer can further comprise a non-complementary tail region, though such a tail is not required. In some embodiments, the reverse primer is a “universal reverse primer,” which indicates that the sequence of the reverse primer can be used in a plurality of different reactions querying different target polynucleotides, but that the reverse primer nonetheless is the same sequence.

[0036] The term “upstream” as used herein takes on its customary meaning in molecular biology, and refers to the location of a region of a polynucleotide that is on the 5′ side of a “downstream” region. Correspondingly, the term “downstream” refers to the location of a region of a polynucleotide that is on the 3′ side of an “upstream” region.

[0037] As used herein, the term “hybridization” refers to the complementary base-pairing interaction of one nucleic acid with another nucleic acid that results in formation of a duplex, triplex, or other higher-ordered structure, and is used herein interchangeably with “annealing.” Typically, the primary interaction is base specific, e.g., A/T and G/C, by Watson/Crick and Hoogsteen-type hydrogen bonding. Base-stacking and hydrophobic interactions can also contribute to duplex stability. Conditions for hybridizing detector probes and primers to complementary and substantially complementary target sequences are well known, e.g., as described in Nucleic Acid Hybridization, A Practical Approach, B. Hames and S. Higgins, eds., IRL Press, Washington, D.C. (1985) and J. Wetmur and N. Davidson, Mol. Biol. 31:349 et seq. (1968). In general, whether such annealing takes place is influenced by, among other things, the length of the polynucleotides and the complementary, the pH, the temperature, the presence of mono- and divalent cations, the proportion of G and C nucleotides in the hybridizing region, the viscosity of the medium, and the presence of denaturants. Such variables influence the time required for hybridization. Thus, the preferred annealing conditions will depend upon the particular application. Such conditions, however, can be routinely determined by the person of ordinary skill in the art without undue experimentation. It will be appreciated that complementarity need not be perfect; there can be a small number of base pair mismatches that will minimally interfere with hybridization between the target sequence and the single stranded nucleic acids of the present teachings. However, if the number of base pair mismatches is so great that no hybridization can occur under minimally stringent conditions then the sequence is generally not a complementary target sequence. Thus, complementarity herein is meant that the probes or primers are sufficiently complementary to the target sequence to hybridize under the selected reaction conditions to achieve the ends of the present teachings.

[0038] As used herein, the term “amplifying” refers to any means by which at least a part of a target polynucleotide, target polynucleotide surrogate, or combinations thereof, is reproduced, typically in a template-dependent manner, including without limitation, a broad range of techniques for amplifying nucleic acid sequences, either linearly or exponentially. Exemplary means for performing an amplifying step include ligase chain reaction (LCR), ligase detection reaction (LDR), ligation followed by Q-replicase amplification, PCR, primer extension, strand displacement amplification (SDA), hyperbranched strand displacement amplification, multiple displacement amplification (MDA), nucleic acid strand-based amplification (NASBA), two-step multiplexed amplifications, rolling circle amplification (RCA) and the like, including multiplex versions or combinations thereof, for example but not limited to, OLA/PCR, PCR/OLA, LDR/PCR, PCR/PCR/LDR, PCR/LDR, LCR/PCR, PCR/LCR (also known as combined chain reaction—CCR), and the like. Descriptions of such techniques can be found in, among other places, Sambrook et al. Molecular Cloning, 3^rd Edition,; Ausbel et al.; PCR Primer: A Laboratory Manual, Diffenbach, Ed., Cold Spring Harbor Press (1995); The Electronic Protocol Book, Chang Bioscience (2002), Msuih et al., J. Clin. Micro. 34:501-07 (1996); The Nucleic Acid Protocols Handbook, R. Rapley, ed., Humana Press, Totowa, N.J. (2002); Abramson et al., Curr Opin Biotechnol. 1993 February; 4(1):41-7, U.S. Pat. No. 6,027,998; U.S. Pat. No. 6,605,451, Barany et al., PCT Publication No. WO 97/31256; Wenz et al., PCT Publication No. WO 01/92579; Day et al., Genomics, 29(1): 152-162 (1995), Ehrlich et al., Science 252:1643-50 (1991); Innis et al., PCR Protocols: A Guide to Methods and Applications, Academic Press (1990); Favis et al., Nature Biotechnology 18:561-64 (2000); and Rabenau et al., Infection 28:97-102 (2000); Belgrader, Barany, and Lubin, Development of a Multiplex Ligation Detection Reaction DNA Typing Assay, Sixth International Symposium on Human Identification, 1995 (available on the world wide web at: promega.com/geneticidproc/ussymp6proc/blegrad.html); LCR Kit Instruction Manual, Cat. #200520, Rev. #050002, Stratagene, 2002; Barany, Proc. Natl. Acad. Sci. USA 88:188-93 (1991); Bi and Sambrook, Nucl. Acids Res. 25:2924-2951 (1997); Zirvi et al., Nucl. Acid Res. 27:e40i-viii (1999); Dean et al., Proc Natl Acad Sci USA 99:5261-66 (2002); Barany and Gelfand, Gene 109:1-11 (1991); Walker et al., Nucl. Acid Res. 20:1691-96 (1992); Polstra et al., BMC Inf. Dis. 2:18-(2002); Lage et al., Genome Res. 2003 February ; 13(2):294-307, and Landegren et al., Science 241:1077-80 (1988), Demidov, V., Expert Rev Mol Diagn. 2002 November; 2(6):542-8., Cook et al., J Microbiol Methods. 2003 May; 53(2):165-74, Schweitzer et al., Curr Opin Biotechnol. 2001 February; 12(1):21-7, U.S. Pat. Nos. 5,830,711, 6,027,889, 5,686,243, Published P.C.T. Application WO0056927A3, and Published P.C.T. Application WO9803673A1. In some embodiments, newly-formed nucleic acid duplexes are not initially denatured, but are used in their double-stranded form in one or more subsequent steps. An extension reaction is an amplifying technique that comprises elongating a linker probe that is annealed to a template in the 5′ to 3′ direction using an amplifying means such as a polymerase and/or reverse transcriptase. According to some embodiments, with appropriate buffers, salts, pH, temperature, and nucleotide triphosphates, including analogs thereof, i.e., under appropriate conditions, a polymerase incorporates nucleotides complementary to the template strand starting at the 3′-end of an annealed linker probe, to generate a complementary strand. In some embodiments, the polymerase used for extension lacks or substantially lacks 5′ exonuclease activity. In some embodiments of the present teachings, unconventional nucleotide bases can be introduced into the amplification reaction products and the products treated by enzymatic (e.g., glycosylases) and/or physical-chemical means in order to render the product incapable of acting as a template for subsequent amplifications. In some embodiments, uracil can be included as a nucleobase in the reaction mixture, thereby allowing for subsequent reactions to decontaminate carryover of previous uracil-containing products by the use of uracil-N-glycosylase (see for example Published P.C.T. Application WO9201814A2). In some embodiments of the present teachings, any of a variety of techniques can be employed prior to amplification in order to facilitate amplification success, as described for example in Radstrom et al., Mol Biotechnol. 2004 February; 26(2):133-46. In some embodiments, amplification can be achieved in a self-contained integrated approach comprising sample preparation and detection, as described for example in U.S. Pat. Nos. 6,153,425 and 6,649,378. Reversibly modified enzymes, for example but not limited to those described in U.S. Pat. No. 5,773,258, are also within the scope of the disclosed teachings. The present teachings also contemplate various uracil-based decontamination strategies, wherein for example uracil can be incorporated into an amplification reaction, and subsequent carry-over products removed with various glycosylase treatments (see for example U.S. Pat. No. 5,536,649, and U.S. Provisional Application 60/584,682 to Andersen et al.,). Those in the art will understand that any protein with the desired enzymatic activity can be used in the disclosed methods and kits. Descriptions of DNA polymerases, including reverse transcriptases, uracil N-glycosylase, and the like, can be found in, among other places, Twyman, Advanced Molecular Biology, BIOS Scientific Publishers, 1999; Enzyme Resource Guide, rev. 092298, Promega, 1998; Sambrook and Russell; Sambrook et al.; Lehninger; PCR: The Basics; and Ausbel et al.

[0039] As used herein, the term “detector probe” refers to a molecule used in an amplification reaction, typically for quantitative or real-time PCR analysis, as well as end-point analysis. Such detector probes can be used to monitor the amplification of the target polynucleotide. In some embodiments, detector probes present in an amplification reaction are suitable for monitoring the amount of amplicon(s) produced as a function of time. Such detector probes include, but are not limited to, the 5′-exonuclease assay (TaqMan® probes described herein (see also U.S. Pat. No. 5,538,848) various stem-loop molecular beacons (see e.g., U.S. Pat. Nos. 6,103,476 and 5,925,517 and Tyagi and Kramer, 1996, Nature Biotechnology 14:303-308), stemless or linear beacons (see, e.g., WO 99/21881), PNA Molecular Beacons™ (see, e.g., U.S. Pat. Nos. 6,355,421 and 6,593,091), linear PNA beacons (see, e.g., Kubista et al., 2001, SPIE 4264:53-58), non-FRET probes (see, e.g., U.S. Pat. No. 6,150,097), Sunrise®/Amplifluor® probes (U.S. Pat. No. 6,548,250), stem-loop and duplex Scorpion™ probes (Solinas et al., 2001, Nucleic Acids Research 29:E96 and U.S. Pat. No. 6,589,743), bulge loop probes (U.S. Pat. No. 6,590,091), pseudo knot probes (U.S. Pat. No. 6,589,250), cyclicons (U.S. Pat. No. 6,383,752), MGB Eclipse™ probe (Epoch Biosciences), hairpin probes (U.S. Pat. No. 6,596,490), peptide nucleic acid (PNA) light-up probes, self-assembled nanoparticle probes, and ferrocene-modified probes described, for example, in U.S. Pat. No. 6,485,901; Mhlanga et al., 2001, Methods 25:463-471; Whitcombe et al., 1999, Nature Biotechnology. 17:804-807; Isacsson et al., 2000, Molecular Cell Probes. 14:321-328; Svanvik et al., 2000, Anal Biochem. 281:26-35; Wolffs et al., 2001, Biotechniques 766:769-771; Tsourkas et al., 2002, Nucleic Acids Research. 30:4208-4215; Riccelli et al., 2002, Nucleic Acids Research 30:4088-4093; Zhang et al., 2002 Shanghai. 34:329-332; Maxwell et al., 2002, J. Am. Chem. Soc. 124:9606-9612; Broude et al., 2002, Trends Biotechnol. 20:249-56; Huang et al., 2002, Chem Res. Toxicol. 15:118-126; and Yu et al., 2001, J. Am. Chem. Soc 14:11155-11161. Detector probes can also comprise quenchers, including without limitation black hole quenchers (Biosearch), Iowa Black (IDT), QSY quencher (Molecular Probes), and Dabsyl and Dabcel sulfonate/carboxylate Quenchers (Epoch). Detector probes can also comprise two probes, wherein for example a fluor is on one probe, and a quencher is on the other probe, wherein hybridization of the two probes together on a target quenches the signal, or wherein hybridization on the target alters the signal signature via a change in fluorescence. Detector probes can also comprise sulfonate derivatives of fluorescenin dyes with SO₃ instead of the carboxylate group, phosphoramidite forms of fluorescein, phosphoramidite forms of CY 5 (commercially available for example from Amersham). In some embodiments, interchelating labels are used such as ethidium bromide, SYBR® Green I (Molecular Probes), and PicoGreen® (Molecular Probes), thereby allowing visualization in real-time, or end point, of an amplification product in the absence of a detector probe. In some embodiments, real-time visualization can comprise both an intercalating detector probe and a sequence-based detector probe can be employed. In some embodiments, the detector probe is at least partially quenched when not hybridized to a complementary sequence in the amplification reaction, and is at least partially unquenched when hybridized to a complementary sequence in the amplification reaction. In some embodiments, the detector probes of the present teachings have a Tm of 63-69 C, though it will be appreciated that guided by the present teachings routine experimentation can result in detector probes with other Tms. In some embodiments, probes can further comprise various modifications such as a minor groove binder (see for example U.S. Pat. No. 6,486,308) to further provide desirable thermodynamic characteristics. In some embodiments, detector probes can correspond to identifying portions or identifying portion complements.

[0040] The term “corresponding” as used herein refers to a specific relationship between the elements to which the term refers. Some non-limiting examples of corresponding include: a linker probe can correspond with a target polynucleotide, and vice versa. A forward primer can correspond with a target polynucleotide, and vice versa. A linker probe can correspond with a forward primer for a given target polynucleotide, and vice versa. The 3′ target-specific portion of the linker probe can correspond with the 3′ region of a target polynucleotide, and vice versa. A detector probe can correspond with a particular region of a target polynucleotide and vice versa. A detector probe can correspond with a particular identifying portion and vice versa. In some cases, the corresponding elements can be complementary. In some cases, the corresponding elements are not complementary to each other, but one element can be complementary to the complement of another element.

[0041] The term “or combinations thereof” as used herein refers to all permutations and combinations of the listed items preceding the term. For example, “A, B, C, or combinations thereof” is intended to include at least one of: A, B, C, AB, AC, BC, or ABC, and if order is important in a particular context, also BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing with this example, expressly included are combinations that contain repeats of one or more item or term, such as BB, AAA, AAB, BBC, AAABCCCC, CBBAAA, CABABB, and so forth. The skilled artisan will understand that typically there is no limit on the number of items or terms in any combination, unless otherwise apparent from the context.

[0042] As used herein, the term “reaction vessel” generally refers to any container in which a reaction can occur in accordance with the present teachings. In some embodiments, a reaction vessel can be an eppendorf tube, and other containers of the sort in common practice in modern molecular biology laboratories. In some embodiments, a reaction vessel can be a well in microtitre plate, a spot on a glass slide, or a well in an Applied Biosystems TaqMan Low Density Array for gene expression (formerly MicroCard™). For example, a plurality of reaction vessels can reside on the same support. In some embodiments, lab-on-a-chip like devices, available for example from Caliper and Fluidgm, can provide for reaction vessels. In some embodiments, various microfluidic approaches as described in U.S. Provisional Application 60/545,674 to Wenz et al., can be employed. It will be recognized that a variety of reaction vessel are available in the art and within the scope of the present teachings.

[0043] As used herein, the term “detection” refers to any of a variety of ways of determining the presence and/or quantity and/or identity of a target polynucleoteide. In some embodiments employing a donor moiety and signal moiety, one may use certain energy-transfer fluorescent dyes. Certain nonlimiting exemplary pairs of donors (donor moieties) and acceptors (signal moieties) are illustrated, e.g., in U.S. Pat. Nos. 5,863,727; 5,800,996; and 5,945,526. Use of some combinations of a donor and an acceptor have been called FRET (Fluorescent Resonance Energy Transfer). In some embodiments, fluorophores that can be used as signaling probes include, but are not limited to, rhodamine, cyanine 3 (Cy 3), cyanine 5 (Cy 5), fluorescein, Vic™, LiZ™, Tamra™, 5-Fam™, 6-Fam™, and Texas Red (Molecular Probes). (Vic™, LIZ™, Tamra™, 5-Fam™, and 6-Fam™ (all available from Applied Biosystems, Foster City, Calif.). In some embodiments, the amount of detector probe that gives a fluorescent signal in response to an excited light typically relates to the amount of nucleic acid produced in the amplification reaction. Thus, in some embodiments, the amount of fluorescent signal is related to the amount of product created in the amplification reaction. In such embodiments, one can therefore measure the amount of amplification product by measuring the intensity of the fluorescent signal from the fluorescent indicator. According to some embodiments, one can employ an internal standard to quantify the amplification product indicated by the fluorescent signal. See, e.g., U.S. Pat. No. 5,736,333. Devices have been developed that can perform a thermal cycling reaction with compositions containing a fluorescent indicator, emit a light beam of a specified wavelength, read the intensity of the fluorescent dye, and display the intensity of fluorescence after each cycle. Devices comprising a thermal cycler, light beam emitter, and a fluorescent signal detector, have been described, e.g., in U.S. Pat. Nos. 5,928,907; 6,015,674; and 6,174,670, and include, but are not limited to the ABI Prism® 7700 Sequence Detection System (Applied Biosystems, Foster City, Calif.), the ABI GeneAmp® 5700 Sequence Detection System (Applied Biosystems, Foster City, Calif.), the ABI GeneAmp® 7300 Sequence Detection System (Applied Biosystems, Foster City, Calif.), and the ABI GeneAmp® 7500 Sequence Detection System (Applied Biosystems). In some embodiments, each of these functions can be performed by separate devices. For example, if one employs a Q-beta replicase reaction for amplification, the reaction may not take place in a thermal cycler, but could include a light beam emitted at a specific wavelength, detection of the fluorescent signal, and calculation and display of the amount of amplification product. In some embodiments, combined thermal cycling and fluorescence detecting devices can be used for precise quantification of target nucleic acid sequences in samples. In some embodiments, fluorescent signals can be detected and displayed during and/or after one or more thermal cycles, thus permitting monitoring of amplification products as the reactions occur in “real time.” In some embodiments, one can use the amount of amplification product and number of amplification cycles to calculate how much of the target nucleic acid sequence was in the sample prior to amplification. In some embodiments, one could simply monitor the amount of amplification product after a predetermined number of cycles sufficient to indicate the presence of the target nucleic acid sequence in the sample. One skilled in the art can easily determine, for any given sample type, primer sequence, and reaction condition, how many cycles are sufficient to determine the presence of a given target polynucleotide. As used herein, determining the presence of a target can comprise identifying it, as well as optionally quantifying it. In some embodiments, the amplification products can be scored as positive or negative as soon as a given number of cycles is complete. In some embodiments, the results may be transmitted electronically directly to a database and tabulated. Thus, in some embodiments, large numbers of samples can be processed and analyzed with less time and labor when such an instrument is used. In some embodiments, different detector probes may distinguish between different target polynucleoteides. A non-limiting example of such a probe is a 5′-nuclease fluorescent probe, such as a TaqMan® probe molecule, wherein a fluorescent molecule is attached to a fluorescence-quenching molecule through an oligonucleotide link element. In some embodiments, the oligonucleotide link element of the 5′-nuclease fluorescent probe binds to a specific sequence of an identifying portion or its complement. In some embodiments, different 5′-nuclease fluorescent probes, each fluorescing at different wavelengths, can distinguish between different amplification products within the same amplification reaction. For example, in some embodiments, one could use two different 5′-nuclease fluorescent probes that fluoresce at two different wavelengths (WL_A and WL_B) and that are specific to two different stem regions of two different extension reaction products (A′ and B′, respectively). Amplification product A′ is formed if target nucleic acid sequence A is in the sample, and amplification product B′ is formed if target nucleic acid sequence B is in the sample. In some embodiments, amplification product A′ and/or B′ may form even if the appropriate target nucleic acid sequence is not in the sample, but such occurs to a measurably lesser extent than when the appropriate target nucleic acid sequence is in the sample. After amplification, one can determine which specific target nucleic acid sequences are present in the sample based on the wavelength of signal detected and their intensity. Thus, if an appropriate detectable signal value of only wavelength WL_A is detected, one would know that the sample includes target nucleic acid sequence A, but not target nucleic acid sequence B. If an appropriate detectable signal value of both wavelengths WL_A and WL_B are detected, one would know that the sample includes both target nucleic acid sequence A and target nucleic acid sequence B. In some embodiments, detection can occur through any of a variety of mobility dependent analytical techniques based on differential rates of migration between different analyte species. Exemplary mobility-dependent analysis techniques include electrophoresis, chromatography, mass spectroscopy, sedimentation, e.g., gradient centrifugation, field-flow fractionation, multi-stage extraction techniques, and the like. In some embodiments, mobility probes can be hybridized to amplification products, and the identity of the target polynucleotide determined via a mobility dependent analysis technique of the eluted mobility probes, as described for example in Published P.C.T. Application WO04/46344 to Rosenblum et al., and WO01/92579 to Wenz et al.,. In some embodiments, detection can be achieved by various microarrays and related software such as the Applied Biosystems Array System with the Applied Biosystems 1700 Chemiluminescent Microarray Analyzer and other commercially available array systems available from Affymetrix, Agilent, Illumina, and Amersham Biosciences, among others (see also Gerry et al., J. Mol. Biol. 292:251-62, 1999; De Bellis et al., Minerva Biotec 14:247-52, 2002; and Stears et al., Nat. Med. 9:140-45, including supplements, 2003). It will also be appreciated that detection can comprise reporter groups that are incorporated into the reaction products, either as part of labeled primers or due to the incorporation of labeled dNTPs during an amplification, or attached to reaction products, for example but not limited to, via hybridization tag complements comprising reporter groups or via linker arms that are integral or attached to reacton products. Detection of unlabeled reaction products, for example using mass spectrometry, is also within the scope of the current teachings.

[0044] FIG. 1 depicts certain compositions according to some embodiments of the present teachings. Top, a miRNA molecule (1, dashed line) is depicted. Middle, a linker probe (2) is depicted, illustrating a 3′ target specific portion (3), a stem (4), and a loop (5). Bottom, a miRNA hybridized to a linker probe is depicted, illustrating the 3′ target specific portion of the linker probe (3) hybridized to the 3′ end region of the miRNA (6).

[0045] As shown in FIG. 2, a target polynucleotide (9, dotted line) is illustrated to show the relationship with various components of the linker probe (10), the detector probe (7), and the reverse primer (8), according to various non-limiting embodiments of the present teachings. For example as shown in FIG. 2A, in some embodiments the detector probe (7) can correspond with the 3′ end region of the target polynucleotide in the amplification product as well as a region upstream from the 3′ end region of the target polynucleotide in the amplification product. (Here, the detector probe is depicted as rectangle (7) with an F and a Q, symbolizing a TaqMan probe with a florophore (F) and a quencher (Q)). Also shown in FIG. 2A, the loop can correspond to the reverse primer (8). In some embodiments as shown in FIG. 2B, the detector probe (7) can correspond with a region of the amplification product corresponding with the 3′ end region of the target polynucleotide in the amplification product, as well as a region upstream from the 3′ end region of the target polynucleotide in the amplification product, as well as the linker probe stem in the amplification product. Also shown in FIG. 2B, the upstream region of the stem, as well as the loop, can correspond to the reverse primer (8). In some embodiments as shown in FIG. 2C, the detector probe can correspond to the amplification product in a manner similar to that shown in FIG. 2B, but the loop can correspond to the reverse primer (8). In some embodiments as shown in FIG. 2D, the detector probe (7) can correspond with the linker probe stem in the amplification product. Also shown in FIG. 2D, the upstream region of the stem, as well as the loop can correspond to the reverse primer (8). It will be appreciated that various related strategies for implementing the different functional regions of these compositions are possible in light of the present teachings, and that such derivations are routine to one having ordinary skill in the art without undue experimentation.

[0046] FIG. 3 depicts the nucleotide relationship for the micro RNA MiR-16 (boxed, 11) according to some embodiments of the present teachings. Shown here is the interrelationship of MiR-16 to a forward primer (12), a linker probe (13), a TaqMan detector probe (14), and a reverse primer (boxed, 15). The TaqMan probe comprises a 3′ minor groove binder (MGB), and a 5′ FAM florophore. It will be appreciated that in some embodiments of the present teachings the detector probes, such as for example TaqMan probes, can hybridize to either strand of an amplification product. For example, in some embodiments the detector probe can hybridize to the strand of the amplification product corresponding to the first strand synthesized. In some embodiments, the detector probe can hybridize to the strand of the amplification product corresponding to the second strand synthesized.

[0047] FIG. 4 depicts a single-plex assay design according to some embodiments of the present teachings. Here, a miRNA molecule (16) and a linker probe (17) are hybridized together (18). The 3′ end of the linker probe of the target-linker probe composition is extended to form an extension product (19) that can be amplified in a PCR. The PCR can comprise a miRNA specific forward primer (20) and a reverse primer (21). The detection of a detector probe (22) during the amplification allows for quantitation of the miRNA.

[0048] FIG. 5 depicts an overview of a multiplex assay design according to some embodiments of the present teachings. Here, a multiplexed hybridization and extension reaction is performed in a first reaction vessel (23). Thereafter, aliquots of the extension reaction products from the first reaction vessel are transferred into a plurality of amplification reactions (here, depicted as PCRs 1, 2, and 3) in a plurality of second reaction vessels. Each PCR can comprise a distinct primer pair and a distinct detector probe. In some embodiments, a distinct primer pair but the same detector probe can be present in each of a plurality of PCRs.

[0049] FIG. 6 depicts a multiplex assay design according to some embodiments of the present teachings. Here, three different miRNAs (24, 25, and 26) are queried in a hybridization reaction comprising three different linker probes (27, 28, and 29). Following hybridization and extension to form extension products (30, 31, and 32), the extension products are divided into three separate amplification reactions. (Though not explicitly shown, it will be appreciated that a number of copies of the molecules depicted by 30, 31, and 32 can be present, such that each of the three amplification reactions can have copies of 30, 31, and 32.) PCR 1 comprises a forward primer specific for mRNA 24 (33), PCR 2 comprises a forward primer specific for miRNA 25 (34), and PCR 3 comprises a forward primer specific for miRNA 26 (35). Each of the forward primers further comprise a non-complementary tail portion. PCR 1, PCR 2, and PCR 3 all comprise the same universal reverse primer 36. Further, PCR 1 comprises a distinct detector probe (37) that corresponds to the 3′ end region of miRNA 24 and the stem of linker probe 27, PCR 2 comprises a distinct detector probe (38) that corresponds to the 3′ end region of miRNA 25 and the stem of linker probe 28, and PCR 3 comprises a distinct detector probe (39) that corresponds to the 3′ region of miRNA 26 and the stem of linker probe 29.

[0050] The present teachings also contemplate reactions comprising configurations other than a linker probe. For example, in some embodiments, two hybridized molecules with a sticky end can be employed, wherein for example an overlapping 3′ sticky end hybridizes with the 3′ end region of the target polynucleotide. Some descriptions of two molecule configurations that can be employed in the present teachings can be found in Chen et al., U.S. Provisional Application 60/517,470. Viewed in light of the present teachings herein, one of skill in the art will appreciate that the approaches of Chen et al., can also be employed to result in extension reaction products that are longer that the target polynucleotide. These longer products can be detected with detector probes by, for example, taking advantage of the additional nucleotides introduced into the reaction products.

[0051] The present teachings also contemplate embodiments wherein the linker probe is ligated to the target polynucleotide, as described for example in Chen et al., U.S. Provisional Application 60/575,661, and the corresponding co-filed U.S. Provisional application co-filed herewith

[0052] Further, it will be appreciated that in some embodiments of the present teachings, the two molecule configurations in Chen et al., U.S. Provisional Application 60/517,470 can be applied in embodiments comprising the linker approaches discussed in Chen et al., U.S. Provisional Application 60/575,661.

[0053] Generally however, the loop structure of the present teachings will enhance the Tm of the target polynucleotide-linker probe duplex. Without being limited to any particular theory, this enhanced Tm could possibly be due to base stacking effects. Also, the characteristics of the looped linker probe of the present teachings can minimize nonspecific priming during the extension reaction, and/or a subsequent amplification reaction such as PCR. Further, the looped linker probe of the present teachings can better differentiate mature and precursor forms of miRNA, as illustrated infra in Example 6.

[0054] The present teachings also contemplate encoding and decoding reaction schemes, wherein a first encoding extension reaction is followed by a second decoding amplification reaction, as described for example in Livak et al., U.S. Provisional Application 60/556,162, Chen et al., U.S. Provisional Application 60/556,157, Andersen et al., U.S. Provisional Application 60/556,224, and Lao et al., U.S. Provisional Application 60/556,163.

[0055] The present teachings also contemplate a variety of strategies to minimize the number of different molecules in multiplexed amplification strategies, as described for example in Whitcombe et al., U.S. Pat. No. 6,270,967.

[0056] In certain embodiments, the present teachings also provide kits designed to expedite performing certain methods. In some embodiments, kits serve to expedite the performance of the methods of interest by assembling two or more components used in carrying out the methods. In some embodiments, kits may contain components in pre-measured unit amounts to minimize the need for measurements by end-users. In some embodiments, kits may include instructions for performing one or more methods of the present teachings. In certain embodiments, the kit components are optimized to operate in conjunction with one another.

[0057] For example, the present teachings provide a kit comprising, a reverse transcriptase and a linker probe, wherein the linker probe comprises a stem, a loop, and a 3′ target-specific portion, wherein the 3′ target-specific portion corresponds to a miRNA. In some embodiments, the kits can comprise a DNA polymerase. In some embodiments, the kits can comprise a primer pair. In some embodiments, the kits can further comprise a forward primer specific for a miRNA, and, a universal reverse primer, wherein the universal reverse primer comprises a nucleotide of the loop of the linker probe. In some embodiments, the kits can comprise a plurality of primer pairs, wherein each primer pair is in one reaction vessel of a plurality of reaction vessels. In some embodiments, the kits can comprise a detector probe. In some embodiments, the detector probe comprises a nucleotide of the linker probe stem in the amplification product or a nucleotide of the linker probe stem complement in the amplification product, and the detector probe further comprises a nucleotide of the 3′ end region of the miRNA in the amplification product or a nucleotide of the 3′ end region of the miRNA complement in the amplification product.

[0058] The present teachings further contemplate kits comprising a means for hybridizing, a means for extending, a means for amplifying, a means for detecting, or combinations thereof.

[0059] While the present teachings have been described in terms of these exemplary embodiments, the skilled artisan will readily understand that numerous variations and modifications of these exemplary embodiments are possible without undue experimentation. All such variations and modifications are within the scope of the current teachings. Aspects of the present teachings may be further understood in light of the following examples, which should not be construed as limiting the scope of the teachings in any way.

[0060] A single-plex reaction was performed in replicate for a collection of mouse miRNAs, and the effect of the presence or absence of ligase, as well as the presence or absence of reverse transcriptase, determined. The results are shown in Table 1 as Ct values.

[0061] First, a 6 ul reaction was set up comprising: 1 ul Reverse Transcription Enzyme Mix (Applied Biosystems part number 4340444) (or 1 ul dH2O), 0.5 ul T4 DNA Ligase (400 units/ul, NEB) (or 0.5 ul dH2O), 0.25 ul 2M KCl, 0.05 ul dNTPs (25 mM each), 0.25 ul T4 Kinase (10 units/ul, NEB), 1 ul 10×T4 DNA ligase buffer (NEB), 0.25 ul Applied Biosystems RNase Inhibitor (10 units/ul), and 2.2 ul dH2O Next, 2 ul of the linker probe (0.25 uM) and RNA samples (2 ul of 0.25 ug/ul mouse lung total RNA (Ambion, product number 7818) were added. Next, the reaction was mixed, spun briefly, and placed on ice for 5 minutes.

[0062] The reaction was then incubated at 16 C for 30 minutes, 42 C for 30 minutes, followed by 85 C for 5 minutes, and then held at 4 C. The reactions were diluted 4 times by adding 30 ul of dH2O prior to the PCR amplification.

[0063] A 10 ul PCR amplification was then set up comprising: 2 ul of diluted reverse transcription reaction product, 1.3 ul 10 uM miRNA specific Forward Primer, 0.7 ul 10 uM Universal Reverse Primer, 0.2 ul TaqMan detector probe, 0.2 ul dNTPs (25 mM each), 0.6 ul dH2O, 5 ul 2× TaqMan master mix (Applied Biosystems, without UNG).

[0064] The reaction was started with a 95 C step for 10 minutes. Then, 40 cycles were performed, each cycle comprising 95 C for 15 seconds, and 60 C for 1 minute.

[0065] Table 1 indicates the results of this experiment.

[0066]

TABLE 1
		Reverse								miRNA
Replicate	Ligase	transcriptase	Let-7a1	mir16	mir20	mir21	mir26a	mir30a	mir224	average
	Yes	Yes	16.8	16.0	19.1	16.8	15.0	21.3	27.3	18.9
	Yes	No	38.7	31.3	39.9	31.9	30.1	33.3	40.0	35.0
I	No	Yes	18.0	14.6	18.3	16.2	14.0	21.3	26.4	18.4
	No	No	40.0	36.6	40.0	40.0	33.8	39.2	40.0	38.5
	Yes	Yes	17.1	16.2	19.3	17.0	15.1	21.4	27.3	19.1
	Yes	No	38.9	31.2	37.6	32.1	30.4	33.4	39.4	34.7
II	No	Yes	18.4	14.8	18.7	16.6	14.3	21.5	26.7	18.7
	No	No	40.0	36.1	40.0	40.0	34.1	40.0	40.0	38.6
Replicate	Yes	Yes	16.9	16.1	19.2	16.9	15.0	21.4	27.3	19.0
Average	Yes	No	38.8	31.2	38.8	32.0	30.3	33.4	39.7	34.9
	No	Yes	18.2	14.7	18.5	16.4	14.1	21.4	26.6	18.6
	No	No	40.0	36.4	40.0	40.0	34.0	39.6	40.0	40.0

[0067] Sequences of corresponding forward primers, reverse primer, and TaqMan probes are shown in Table 2.

[0068]

TABLE 2
miRNA ID	miRNA sequences
miR-16	uagcagcacguaaauauuggcg
miR-20	uaaagugcuuauagugcaggua
miR-21	uagcuuaucagacugauguuga
miR-22	aagcugccaguugaagaacugu
miR-26a	uucaaguaauccaggauaggcu
miR-29	cuagcaccaucugaaaucgguu
miR-30a	cuuucagucggauguuugcagc
miR-34	uggcagugucuuagcugguugu
miR-200b	cucuaauacugccugguaaugaug
miR-323	gcacauuacacggucgaccucu
miR-324-5	cgcauccccuagggcauuggugu
let-7a1	ugagguaguagguuguauaguu
Linker probe	Linker probe sequences
miR-16linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCGCCAA
miR20LinR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTACCTG
miR-21linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACTCAACA
miR-22linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAGTT
miR-26alinR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGCCTA
miR-29linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCGA
miR30LinR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGCTGCA
miR-34linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACAACC
miR-200blinR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCATCAT
miR-323linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAGAGGT
miR-324-5linR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACACACCA
let7aLinR6	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACTAT
Forward primer ID	Forward primer sequences
miR-16F55	CGCGCTAGCAGCACGTAAAT
miR-20F56	GCCGCTAAAGTGCTTATAGTGC
miR-21F56	GCCCGCTAGCTTATCAGACTGATG
miR-22F56	GCCTGAAGCTGCCAGTTGA
miR-26aF54	CCGGCGTTCAAGTAATCCAGGA
miR-29F56	GCCGCTAGCACCATCTGAAA
miR-30aF58	GCCCCTTTCAGTCGGATGTTT
miR-34F56	GCCCGTGGCAGTGTCTTAG
miR-200bF56	GCCCCTCTAATACTGCCTGG
miR-323F58	GCCACGCACATTACACGGTC
miR-324-5F56	GCCACCATCCCCTAGGGC
let-7a1F56	GCCGCTGAGGTAGTAGGTTGT
TaqMan probe ID	TaqMan probe sequences
miR-16_Tq8F67	(6FAM) ATACGACCGCCAATAT (MGB)
miR20_Tq8F68	(6FAM) CTGGATACGACTACCTG (MGB)
miR-21_Tq8F68	(6FAM) CTGGATACGACTCAACA (MGB)
miR-22_Tq8F68	(6FAM) TGGATACGACACAGTTCT (MGB)
miR-26a_Tq8F69	(6FAM) TGGATACGACAGCCTATC (MGB)
miR-29_Tq8F68	(6FAM) TGGATACGACAACCGAT (MGB)
miR30_Tq8F68	(6FAM) CTGGATACGACGCTGC (MGB)
miR-34_Tq8F68	(6FAM) ATACGACACAACCAGC (MGB)
miR-200b_Tq8F67	(6FAM) ATACGACCATCATTACC (MGB)
miR-323_Tg8F67	(6FAM) CTGGATACGACAGAGGT (MGB)
miR-324_5Tq8F68	(6FAM) ATACGACACACCAATGC (MGB)
let7a_Tg8F68	(6FAM) TGGATACGACAACTATAC (MGB)
Universal reverse
primer ID	Reverse primer sequence
miR-UP-R67.8	GTGCAGGGTCCGAGGT

[0069] A multiplex (12-plex) assay was performed and the results compared to a corresponding collection of single-plex reactions. Additionally, the effect of the presence or absence of ligase, as well as the presence or absence of reverse transcriptase, was determined. The experiments were performed essentially the same as in Example 1, and the concentration of each linker in the 12-plex reaction was 0.05 uM, thereby resulting in a total linker probe concentration of 0.6 uM. Further, the diluted 12-plex reverse transcription product was split into 12 different PCR amplification reactions, wherein a miRNA forward primer and a universal reverse primer and a detector probe where in each amplification reaction. The miRNA sequences, Forward primers, and TaqMan detector probes are included in Table 2. The results are shown in Table 3.

[0070]

TABLE 3
Singleplex vs. Multiplex Assay With Or Without T4 DNA Ligase
	1-plex Ct	12-plex Ct	Ligation +
	Ligation +	RT	Ligation +	RT	RT	1-vs.
miRNA	RT	only	RT	only	vs RT only	12-plex
let-7a1	17.8	16.3	17.6	17.0	1.0	−0.3
mir-16	16.0	15.1	16.1	15.3	0.9	−0.1
mir-20	19.3	18.7	19.8	19.5	0.4	−0.6
mir-21	17.0	15.8	17.1	16.3	1.0	−0.3
mir-22	21.6	20.4	21.4	20.7	1.0	−0.1
mir-26a	15.2	14.3	15.6	14.9	0.8	−0.4
mir-29	17.9	16.8	17.7	17.0	0.9	0.0
mir-30a	20.7	19.9	21.2	20.7	0.7	−0.7
mir-34	21.3	20.4	22.0	21.0	0.9	−0.6
mir-200b	19.9	19.2	21.1	20.2	0.8	−1.0
mir-323	32.5	31.2	33.6	32.3	1.3	−1.1
mir-324-5	24.7	23.1	25.0	24.4	1.1	−0.8
Average	20.3	19.3	20.7	19.9	0.9	−0.5

[0071] An experiment was performed to determine the effect of buffer conditions on reaction performance. In one set of experiments, a commercially available reverse transcription buffer from Applied Biosystems (part number 43400550) was employed in the hybridization and extension reaction. In a corresponding set of experiments, a commercially available T4 DNA ligase buffer (NEB) was employed in the hybridization and extension reaction. The experiments were performed as single-plex format essentially as described for Example 1, and each miRNA was done in triplicate. The results are shown in Table 4, comparing RT buffer (AB part #4340550) vs T4 DNA ligase buffer.

[0072]

	TABLE 4
			RT
			vs
			T4
	RT Buffer	T4 DNA Ligase Buffer	Buff-
	I	II	III	Mean	I	II	III	Mean	er
let-7a1	22.7	22.8	22.8	22.8	20.8	20.7	20.6	20.7	2.1
mir-16	18.4	18.5	18.6	18.5	17.7	17.8	17.9	17.8	0.7
mir-20	23.6	23.7	23.8	23.7	23.1	23.1	23.0	23.1	0.6
mir-21	20.4	20.4	20.5	20.4	19.4	19.3	19.2	19.3	1.1
mir-22	24.0	23.9	24.1	24.0	22.7	22.7	22.7	22.7	1.3
mir-26a	19.8	19.9	20.1	19.9	18.9	19.0	19.0	18.9	1.0
mir-29	21.3	21.3	21.4	21.3	20.5	20.6	20.5	20.5	0.8
mir-30a	24.4	24.4	24.4	24.4	23.6	23.4	23.6	23.5	0.9
mir-34	24.9	24.8	25.1	25.0	23.0	23.1	23.2	23.1	1.9
mir-	25.8	25.8	25.9	25.9	24.6	24.6	24.8	24.7	1.2
200b
mir-323	34.6	34.5	34.8	34.6	34.7	34.2	34.5	34.5	0.2
mir-	26.0	26.0	26.1	26.0	25.4	25.7	25.6	25.6	0.5
324-5
Average	23.8	23.8	24.0	23.9	22.9	22.8	22.9	22.9	1.0

[0073] An experiment was performed to examine the effect of ligase and kinase in a real-time miRNA amplification reaction. Here, twelve single-plex reactions were performed in duplicate, essentially as described in Example 1. Results are shown in Table 5.

[0074]

	TABLE 5
	Ligase & Kinase	No Ligase/No Kinase
	I	II	Mean	I	II	Mean
let-7a1	17.7	17.9	17.8	16.2	16.4	16.3
mir-16	15.9	16.2	16.0	15.0	15.2	15.1
mir-20	19.1	19.6	19.3	18.6	18.9	18.7
mir-21	16.9	17.2	17.0	15.7	15.9	15.8
mir-22	21.4	21.7	21.6	20.3	20.5	20.4
mir-26a	15.0	15.4	15.2	14.3	14.4	14.3
mir-29	17.9	18.0	17.9	16.7	16.8	16.8
mir-30a	20.6	20.8	20.7	19.8	20.0	19.9
mir-34	21.1	21.5	21.3	20.4	20.5	20.4
mir-200b	19.8	20.0	19.9	19.2	19.3	19.2
mir-323	32.3	32.6	32.5	31.1	31.2	31.2
mir-324-5	24.6	24.8	24.7	23.0	23.3	23.1
Average	20.2	20.5	20.3	19.2	19.4	19.3

[0075] An experiment was performed to determine the effect of sample material on Ct values in a real-time miRNA amplification reaction. Here, cells, GuHCl lysate, Tris lysate, and Purified RNA were compared. The cells were NIH3T3 cells. The Purified RNA was collected using the commercially available mirVana mRNA isolation kit for Ambion (catalog number 1560). A Tris lysate, and a Guanidine lysate (GuHCl) (commercially available from Applied Biosystems), were prepared as follows:

[0076] For the Tris lysate, a 1× lysis buffer comprised 10 mM Tris-HCl, pH 8.0, 0.02% Sodium Azide, and 0.03% Tween-20. Trypsinized cells were pelleted by centrifugation at 1500 rpm for 5 minutes. The growth media was removed by aspiration, being careful that the cell pellet was not disturbed. PBS was added to bring the cells to 2×10³ cells/ul. Next 10 ul of cell suspension was mixed with 10 ul of a 2× lysis buffer and spun briefly. The tubes were then immediately incubated for 5 minutes at 95 C, and then immediately placed in a chilled block on ice for 2 minutes. The tubes were then mixed well and spun briefly at full speed before use (or optionally, stored at −20 C).

[0077] For the GuHCl lysate, a 1× lysis buffer comprised 2.5M GuHCl, 150 mM MES pH 6.0, 200 mM NaCl, 0.75% Tween-20. Trypsinized cells were pelleted by centrifugation at 1500 rpm for 5 minutes. The growth media was removed by aspiration, being careful that the cell pellet was not disturbed. The cell pellet was then re-suspended in 1×PBS, Ca++ and Mg++ free to bring cells to 2×10⁴ cells/uL. Then, 1 volume of 2× lysis buffer was added. To ensure complete nucleic acid release, this was followed by pipetting up and down ten times, followed by a brief spin. Results are shown in Table 6.

Similar results were obtained for a variety of cell lines, including NIH/3T3, OP9, A549, and HepG2 cells.

[0078]

	TABLE 6
	Ct
miRNA ID	Cells	GuHCl lysate	Tris lysate	Purified RNA
let-7a1	24.9	31.3	28.2	31.5
mir-16	22.3	25.2	22.3	24.9
mir-20	22.7	26.0	24.1	26.1
mir-21	21.3	24.2	22.0	24.7
mir-22	30.3	28.6	27.2	28.8
mir-26a	25.6	31.0	27.9	31.4
mir-29	27.2	27.9	26.5	27.4
mir-30a	26.1	32.2	28.9	30.7
mir-34	26.8	30.3	26.4	27.4
mir-200b	40.0	40.0	40.0	40.0
mir-323	30.1	34.7	31.1	31.8
mir-324-5	28.6	29.7	28.3	29.3
Average	27.2	30.1	27.8	29.5

[0079] An experiment was performed to demonstrate the ability of the reaction to selectively quantity mature miRNA in the presence of precursor miRNA. Here, let-7a miRNA and mir-26b miRNA were queried in both mature form as well as in their precursor form. Experiments were performed essentially as described for Example 1 in the no ligase condition, done in triplicate, with varying amounts of target material as indicated. Results are shown in Table 7. The sequences examined were as follows:

Mature let-7a, Seq ID NO:

[0080]

UGAGGUAGUAGGUUGUAUAGUU

Precursor let-7a, SEQ ID NO: (Note that the underlined sequences corresponds to the Mature let-7a.)

[0081]

	GGGUGAGGUAGUAGGUUGUAUAGUUUGGGGCUCUGCCCUGCUAUGGGAUAA
	CUAUACAAUCUACUGUCUUUCCU

Mature mir-26b, SEQ ID NO:

[0082]

UUCAAGUAAUUCAGGAUAGGU

Precursor mir-26b of SEQ ID NO: (Note that the underlined sequences corresponds to the Mature mir-26b.)

[0083]

	CCGGGACCCAGUUCAAGUAAUUCAGGAUAGGUUGUGUGCUGUCCAGCCUGU
	UCUCCAUUACUUGGCUCGGGGACCGG

[0084]

	TABLE 7
	Mouse	Synthetic	Synthetic
	lung	miRNA	precursor	Assay specific for (CT)
Target	RNA (ng)	(fM)	(fM)	miRNA	Precursor
Let-7a	0	0	0	40.0 ± 0.0	40.0 ± 0.0
(let-7a3)	0	10	0	24.2 ± 0.3	40.0 ± 0.0
	0	100	0	21.0 ± 0.2	40.0 ± 0.0
	0	0	10	35.0 ± 1.0	25.0 ± 0.1
	0	0	100	31.0 ± 0.1	21.5 ± 0.1
	10	0	0	19.1 ± 0.4	40.0 ± 0.0
Mir-26b	0	0	0	40.0 ± 0.0	40.0 ± 0.0
	0	10	0	23.1 ± 0.1	40.0 ± 0.0
	0	100	0	19.7 ± 0.1	40.0 ± 0.0
	0	0	10	32.9 ± 0.4	25.7 ± 0.0
	0	0	100	28.9 ± 0.2	22.3 ± 0.0
	10	0	0	20.5 ± 0.1	28.0 ± 0.2

[0085] An experiment was performed on synthetic let-7a miRNA to assess the number of 3′ nucleotides in the 3′ target specific portion of the linker probe that correspond with the 3′ end region of the miRNA. The experiment was performed as essentially as described supra for Example 1 for the no ligase condition, and results are shown in Table 8 as means and standard deviations of Ct values.

[0086]

TABLE 8
miRNA assay components:	let-7a
miRNA synthetic target:	let-7a
No. 3′ ssDNA
linker probe target specific	CT values & statistics
portion bases	I	II	III	Average	SD
7	29.4	29.1	29.3	29.3	0.1
6	30.1	29.9	30.2	30.1	0.2
5	33.9	33.2	33.8	33.6	0.4
4	40.0	39.2	40.0	39.7	0.4

In some embodiments, 3′ target specific portions of linker probes preferably comprise 5 nucleotides that correspond to the 3′ end region of miRNAs. For example, miR-26a and miR-26b differ by only 2 bases, one of which is the 3′ end nucleotide of miR-26a. Linker probes comprising 5 nucleotides at their 3′ target specific portions can be employed to selectively detect miR-26a versus miR-26b.

[0087] Additional strategies for using the linker probes of the present teachings in the context of single step assays, as well as in the context of short primer compositions, can be found in filed U.S. Provisional Application “Compositions, Methods, and Kits for Identifying and Quantitating Small RNA Molecules” by Lao and Straus, as well as in Elfaitouri et al., J. Clin. Virol. 2004, 30(2): 150-156.

[0088] The present teachings further contemplate linker probe compositions comprising 3′ target specific portions corresponding to any micro RNA sequence, including but without limitation, those sequences shown in Table 9, including C. elegans (cel), mouse (mmu), human (hsa), drosophila (dme), rat (rno), and rice (osa).

[0089]

TABLE 9
cel-let-7	mmu-let-7g
ugagguaguagguuguauaguu	ugagguaguaguuuguacagu
cel-lin-4	mmu-let-7i
ucccugagaccucaaguguga	ugagguaguaguuugugcu
cel-miR-1	mmu-miR-1
uggaauguaaagaaguaugua	uggaauguaaagaaguaugua
cel-miR-2	mmu-miR-15b
uaucacagccagcuuugaugugc	uagcagcacaucaugguuuaca
cel-miR-34	mmu-miR-23b
aggcagugugguuagcugguug	aucacauugccagggauuaccac
cel-miR-35	mmu-miR-27b
ucaccggguggaaacuagcagu	uucacaguggcuaaguucug
cel-miR-36	mmu-miR-29b
ucaccgggugaaaauucgcaug	uagcaccauuugaaaucagugu
cel-miR-37	mmu-miR-30a*
ucaccgggugaacacuugcagu	uguaaacauccucgacuggaagc
cel-miR-38	mmu-miR-30a
ucaccgggagaaaaacuggagu	cuuucagucggauguuugcagc
cel-miR-39	mmu-miR-30b
ucaccggguguaaaucagcuug	uguaaacauccuacacucagc
cel-miR-40	mmu-miR-99a
ucaccggguguacaucagcuaa	acccguagauccgaucuugu
cel-miR-41	mmu-miR-99b
ucaccgggugaaaaaucaccua	cacccguagaaccgaccuugcg
cel-miR-42	mmu-miR-101
caccggguuaacaucuacag	uacaguacugugauaacuga
cel-miR-43	mmu-miR-124a
uaucacaguuuacuugcugucgc	uuaaggcacgcggugaaugcca
cel-miR-44	mmu-miR-125a
ugacuagagacacauucagcu	ucccugagacccuuuaaccugug
cel-miR-45	mmu-miR-125b
ugacuagagacacauucagcu	ucccugagacccuaacuuguga
cel-miR-46	mmu-miR-126*
ugucauggagucgcucucuuca	cauuauuacuuuugguacgcg
cel-miR-47	mmu-miR-126
ugucauggaggcgcucucuuca	ucguaccgugaguaauaaugc
cel-miR-48	mmu-miR-127
ugagguaggcucaguagaugcga	ucggauccgucugagcuuggcu
cel-miR-49	mmu-miR-128a
aagcaccacgagaagcugcaga	ucacagugaaccggucucuuuu
cel-miR-50	mmu-miR-130a
ugauaugucugguauucuuggguu	cagugcaauguuaaaagggc
cel-miR-51	mmu-miR-9
uacccguagcuccuauccauguu	ucuuugguuaucuagcuguauga
cel-miR-52	mmu-miR-9*
cacccguacauauguuuccgugcu	uaaagcuagauaaccgaaagu
cel-miR-53	mmu-miR-132
cacccguacauuuguuuccgugcu	uaacagucuacagccauggucg
cel-miR-54	mmu-miR-133a
uacccguaaucuucauaauccgag	uugguccccuucaaccagcugu
cel-miR-55	mmu-miR-134
uacccguauaaguuucugcugag	ugugacugguugaccagaggg
cel-miR-56*	mmu-miR-135a
uggcggauccauuuuggguugua	uauggcuuuuuauuccuauguga
cel-miR-56	mmu-miR-136
uacccguaauguuuccgcugag	acuccauuuguuuugaugaugga
cel-miR-57	mmu-miR-137
uacccuguagaucgagcugugugu	uauugcuuaagaauacgcguag
cel-miR-58	mmu-miR-138
ugagaucguucaguacggcaau	agcugguguugugaauc
cel-miR-59	mmu-miR-140
ucgaaucguuuaucaggaugaug	agugguuuuacccuaugguag
cel-miR-60	mmu-miR-141
uauuaugcacauuuucuaguuca	aacacugucugguaaagaugg
cel-miR-61	mmu-miR-142-5p
ugacuagaaccguuacucaucuc	cauaaaguagaaagcacuac
cel-miR-62	mmu-miR-142-3p
ugauauguaaucuagcuuacag	uguaguguuuccuacuuuaugg
cel-miR-63	mmu-miR-144
uaugacacugaagcgaguuggaaa	uacaguauagaugauguacuag
cel-miR-64	mmu-miR-145
uaugacacugaagcguuaccgaa	guccaguuuucccaggaaucccuu
cel-miR-65	mmu-miR-146
uaugacacugaagcguaaccgaa	ugagaacugaauuccauggguu
cel-miR-66	mmu-miR-149
caugacacugauuagggauguga	ucuggcuccgugucuucacucc
cel-miR-67	mmu-miR-150
ucacaaccuccuagaaagaguaga	ucucccaacccuuguaccagug
cel-miR-68	mmu-miR-151
ucgaagacucaaaaguguaga	cuagacugaggcuccuugagg
cel-miR-69	mmu-miR-152
ucgaaaauuaaaaaguguaga	ucagugcaugacagaacuugg
cel-miR-70	mmu-miR-153
uaauacgucguugguguuuccau	uugcauagucacaaaaguga
cel-miR-71	mmu-miR-154
ugaaagacauggguaguga	uagguuauccguguugccuucg
cel-miR-72	mmu-miR-155
aggcaagauguuggcauagc	uuaaugcuaauugugauagggg
cel-miR-73	mmu-miR-10b
uggcaagauguaggcaguucagu	cccuguagaaccgaauuugugu
cel-miR-74	mmu-miR-129
uggcaagaaauggcagucuaca	cuuuuugcggucugggcuugcu
cel-miR-75	mmu-miR-181a
uuaaagcuaccaaccggcuuca	aacauucaacgcugucggugagu
cel-miR-76	mmu-miR-182
uucguuguugaugaagccuuga	uuuggcaaugguagaacucaca
cel-miR-77	mmu-miR-183
uucaucaggccauagcugucca	uauggcacugguagaauucacug
cel-miR-78	mmu-miR-184
uggaggccugguuguuugugc	uggacggagaacugauaagggu
cel-miR-79	mmu-miR-185
auaaagcuagguuaccaaagcu	uggagagaaaggcaguuc
cel-miR-227	mmu-miR-186
agcuuucgacaugauucugaac	caaagaauucuccuuuugggcuu
cel-miR-80	mmu-miR-187
ugagaucauuaguugaaagccga	ucgugucuuguguugcagccgg
cel-miR-81	mmu-miR-188
ugagaucaucgugaaagcuagu	caucccuugcaugguggagggu
cel-miR-82	mmu-miR-189
ugagaucaucgugaaagccagu	gugccuacugagcugauaucagu
cel-miR-83	mmu-miR-24
uagcaccauauaaauucaguaa	uggcucaguucagcaggaacag
cel-miR-84	mmu-miR-190
ugagguaguauguaauauugua	ugauauguuugauauauuaggu
cel-miR-85	mmu-miR-191
uacaaaguauuugaaaagucgugc	caacggaaucccaaaagcagcu
cel-miR-86	mmu-miR-193
uaagugaaugcuuugccacaguc	aacuggccuacaaagucccag
cel-miR-87	mmu-miR-194
gugagcaaaguuucaggugu	uguaacagcaacuccaugugga
cel-miR-90	mmu-miR-195
ugauauguuguuugaaugcccc	uagcagcacagaaauauuggc
cel-miR-124	mmu-miR-199a
uaaggcacgcggugaaugcca	cccaguguucagacuaccuguuc
cel-miR-228	mmu-miR-199a*
aauggcacugcaugaauucacgg	uacaguagucugcacauugguu
cel-miR-229	mmu-miR-200b
aaugacacugguuaucuuuuccaucgu	uaauacugccugguaaugaugac
cel-miR-230	mmu-miR-201
guauuaguugugcgaccaggaga	uacucaguaaggcauuguucu
cel-miR-231	mmu-miR-202
uaagcucgugaucaacaggcagaa	agagguauagcgcaugggaaga
cel-miR-232	mmu-miR-203
uaaaugcaucuuaacugcgguga	ugaaauguuuaggaccacuag
cel-miR-233	mmu-miR-204
uugagcaaugcgcaugugcggga	uucccuuugucauccuaugccug
cel-miR-234	mmu-miR-205
uuauugcucgagaauacccuu	uccuucauuccaccggagucug
cel-miR-235	mmu-miR-206
uauugcacucuccccggccuga	uggaauguaaggaagugugugg
cel-miR-236	mmu-miR-207
uaauacugucagguaaugacgcu	gcuucuccuggcucuccucccuc
cel-miR-237	mmu-miR-122a
ucccugagaauucucgaacagcuu	uggagugugacaaugguguuugu
cel-miR-238	mmu-miR-143
uuuguacuccgaugccauucaga	ugagaugaagcacuguagcuca
cel-miR-239a	mmu-miR-30e
uuuguacuacacauagguacugg	uguaaacauccuugacugga
cel-miR-239b	mmu-miR-290
uuguacuacacaaaaguacug	cucaaacuaugggggcacuuuuu
cel-miR-240	mmu-miR-291-5p
uacuggcccccaaaucuucgcu	caucaaaguggaggcccucucu
cel-miR-241	mmu-miR-291-3p
ugagguaggugcgagaaauga	aaagugcuuccacuuugugugcc
cel-miR-242	mmu-miR-292-5p
uugcguaggccuuugcuucga	acucaaacugggggcucuuuug
cel-miR-243	mmu-miR-292-3p
cgguacgaucgcggcgggauauc	aagugccgccagguuuugagugu
cel-miR-244	mmu-miR-293
ucuuugguuguacaaagugguaug	agugccgcagaguuuguagugu
cel-miR-245	mmu-miR-294
auugguccccuccaaguagcuc	aaagugcuucccuuuugugugu
cel-miR-246	mmu-miR-295
uuacauguuucggguaggagcu	aaagugcuacuacuuuugagucu
cel-miR-247	mmu-miR-296
ugacuagagccuauucucuucuu	agggcccccccucaauccugu
cel-miR-248	mmu-miR-297
uacacgugcacggauaacgcuca	auguaugugugcaugugcaug
cel-miR-249	mmu-miR-298
ucacaggacuuuugagcguugc	ggcagaggagggcuguucuucc
cel-miR-250	mmu-miR-299
ucacagucaacuguuggcaugg	ugguuuaccgucccacauacau
cel-miR-251	mmu-miR-300
uuaaguaguggugccgcucuuauu	uaugcaagggcaagcucucuuc
cel-miR-252	mmu-miR-301
uaaguaguagugccgcagguaac	cagugcaauaguauugucaaagc
cel-miR-253	mmu-miR-302
cacaccucacuaacacugacc	uaagugcuuccauguuuugguga
cel-miR-254	mmu-miR-34c
ugcaaaucuuucgcgacuguagg	aggcaguguaguuagcugauugc
cel-miR-256	mmu-miR-34b
uggaaugcauagaagacugua	uaggcaguguaauuagcugauug
cel-miR-257	mmu-let-7d
gaguaucaggaguacccaguga	agagguaguagguugcauagu
cel-miR-258	mmu-let-7d*
gguuuugagaggaauccuuuu	cuauacgaccugcugccuuucu
cel-miR-259	mmu-miR-106a
aaaucucauccuaaucuggua	caaagugcuaacagugcaggua
cel-miR-260	mmu-miR-106b
gugaugucgaacucuuguag	uaaagugcugacagugcagau
cel-miR-261	mmu-miR-130b
uagcuuuuuaguuuucacg	cagugcaaugaugaaagggcau
cel-miR-262	mmu-miR-19b
guuucucgauguuuucugau	ugugcaaauccaugcaaaacuga
cel-miR-264	mmu-miR-30c
ggcgggugguuguuguuaug	uguaaacauccuacacucucagc
cel-miR-265	mmu-miR-30d
ugagggaggaagggugguau	uguaaacauccccgacuggaag
cel-miR-266	mmu-miR-148a
aggcaagacuuuggcaaagc	ucagugcacuacagaacuuugu
cel-miR-267	mmu-miR-192
cccgugaagugucugcugca	cugaccuaugaauugaca
cel-miR-268	mmu-miR-196
ggcaagaauuagaagcaguuuggu	uagguaguuucauguuguugg
cel-miR-269	mmu-miR-200a
ggcaagacucuggcaaaacu	uaacacugucugguaacgaugu
cel-miR-270	mmu-miR-208
ggcaugauguagcaguggag	auaagacgagcaaaaagcuugu
cel-miR-271	mmu-let-7a
ucgccgggugggaaagcauu	ugagguaguagguuguauaguu
cel-miR-272	mmu-l-et-7b
uguaggcauggguguuug	ugagguaguagguugugugguu
cel-miR-273	mmu-let-7c
ugcccguacugugucggcug	ugagguaguagguuguaugguu
cel-miR-353	mmu-let-7e
caauugccauguguugguauu	ugagguaggagguuguauagu
cel-miR-354	mmu-let-7f
accuuguuuguugcugcuccu	ugagguaguagauuguauaguu
cel-miR-355	mmu-miR-15a
uuuguuuuagccugagcuaug	uagcagcacauaaugguuugug
cel-miR-356	mmu-miR-16
uugagcaacgcgaacaaauca	uagcagcacguaaauauuggcg
cel-miR-357	mmu-miR-18
uaaaugccagucguugcagga	uaaggugcaucuagugcagaua
cel-miR-358	mmu-miR-20
caauugguaucccugucaagg	uaaagugcuuauagugcagguag
cel-miR-359	mmu-miR-21
ucacuggucuuucucugacga	uagcuuaucagacugauguuga
cel-miR-360	mmu-miR-22
ugaccguaaucccguucacaa	aagcugccaguugaagaacugu
cel-lsy-6	mmu-miR-23a
uuuuguaugagacgcauuucg	aucacauugccagggauuucc
cel-miR-392	mmu-miR-26a
uaucaucgaucacgugugauga	uucaaguaauccaggauaggcu
	mmu-miR-26b
	uucaaguaauucaggauagguu
hsa-let-7a	mmu-miR-29a
ugagguaguagguuguauaguu	cuagcaccaucugaaaucgguu
hsa-let-7b	mmu-miR-29c
ugagguaguagguugugugguu	uagcaccauuugaaaucgguua
hsa-let-7c	mmu-miR-27a
ugagguaguagguuguaugguu	uucacaguggcuaaguuccgc
hsa-let-7d	mmu-miR-31
agagguaguagguugcauagu	aggcaagaugcuggcauagcug
hsa-let-7e	mmu-miR-92
ugagguaggagguuguauagu	uauugcacuugucccggccug
hsa-let-7f	mmu-miR-93
ugagguaguagauuguauaguu	caaagugcuguucgugcagguag
hsa-miR-15a	mmu-miR-96
uagcagcacauaaugguuugug	uuuggcacuagcacauuuuugcu
hsa-miR-16	mmu-miR-34a
uagcagcacguaaauauuggcg	uggcagugucuuagcugguuguu
hsa-miR-17-5p	mmu-miR-98
caaagugcuuacagugcagguagu	ugagguaguaaguuguauuguu
hsa-miR-17-3p	mmu-miR-103
acugcagugaaggcacuugu	agcagcauuguacagggcuauga
hsa-miR-18	mmu-miR-323
uaaggugcaucuagugcagaua	gcacauuacacggucgaccucu
hsa-miR-19a	mmu-miR-324-5p
ugugcaaaucuaugcaaaacuga	cgcauccccuagggcauuggugu
hsa-miR-19b	mmu-miR-324-3p
ugugcaaauccaugcaaaacuga	ccacugccccaggugcugcugg
hsa-miR-20	mmu-miR-325
uaaagugcuuauagugcaggua	ccuaguaggugcucaguaagugu
hsa-miR-21	mmu-miR-326
uagcuuaucagacugauguuga	ccucugggcccuuccuccagu
hsa-miR-22	mmu-miR-328
aagcugccaguugaagaacugu	cuggcccucucugcccuuccgu
hsa-miR-23a	mmu-miR-329
aucacauugccagggauuucc	aacacacccagcuaaccuuuuu
hsa-miR-189	mmu-miR-330
gugccuacugagcugauaucagu	gcaaagcacagggccugcagaga
hsa-miR-24	mmu-miR-331
uggcucaguucagcaggaacag	gccccugggccuauccuagaa
hsa-miR-25	mmu-miR-337
cauugcacuugucucggucuga	uucagcuccuauaugaugccuuu
hsa-miR-26a	mmu-miR-338
uucaaguaauccaggauaggcu	uccagcaucagugauuuuguuga
hsa-miR-26b	mmu-miR-339
uucaaguaauucaggauaggu	ucccuguccuccaggagcuca
hsa-miR-27a	mmu-miR-340
uucacaguggcuaaguuccgcc	uccgucucaguuacuuuauagcc
hsa-miR-28	mmu-miR-341
aaggagcucacagucuauugag	ucgaucggucggucggucagu
hsa-miR-29a	mmu-miR-342
cuagcaccaucugaaaucgguu	ucucacacagaaaucgcacccguc
hsa-miR-30a*	mmu-miR-344
uguaaacauccucgacuggaagc	ugaucuagccaaagccugacugu
hsa-miR-30a	mmu-miR-345
cuuucagucggauguuugcagc	ugcugaccccuaguccagugc
hsa-miR-31	mmu-miR-346
ggcaagaugcuggcauagcug	ugucugcccgagugccugccucu
hsa-miR-32	mmu-miR-350
uauugcacauuacuaaguugc	uucacaaagcccauacacuuucac
hsa-miR-33	mmu-miR-135b
gugcauuguaguugcauug	uauggcuuuucauuccuaugug
hsa-miR-92	mmu-miR-101b
uauugcacuugucccggccugu	uacaguacugugauagcugaag
hsa-miR-93	mmu-miR-107
aaagugcuguucgugcagguag	agcagcauuguacagggcuauca
hsa-miR-95	mmu-miR-10a
uucaacggguauuuauugagca	uacccuguagauccgaauuugug
hsa-miR-96	mmu-miR-17-5p
uuuggcacuagcacauuuuugc	caaagugcuuacagugcagguagu
hsa-miR-98	mmu-miR-17-3p
ugagguaguaaguuguauuguu	acugcagugagggcacuugu
hsa-miR-99a	mmu-miR-19a
aacccguagauccgaucuugug	ugugcaaaucuaugcaaaacuga
hsa-miR-100	mmu-miR-25
aacccguagauccgaacuugug	cauugcacuugucucggucuga
hsa-miR-101	mmu-miR-28
uacaguacugugauaacugaag	aaggagcucacagucuauugag
hsa-miR-29b	mmu-miR-32
uagcaccauuugaaaucagu	uauugcacauuacuaaguugc
hsa-miR-103	mmu-miR-100
agcagcauuguacagggcuauga	aacccguagauccgaacuugug
hsa-miR-105	mmu-miR-139
ucaaaugcucagacuccugu	ucuacagugcacgugucu
hsa-miR-106a	mmu-miR-200c
aaaagugcuuacagugcagguagc	aauacugccggguaaugaugga
hsa-miR-107	mmu-miR-210
agcagcauuguacagggcuauca	cugugcgugugacagcggcug
hsa-miR-192	mmu-miR-212
cugaccuaugaauugacagcc	uaacagucuccagucacggcc
hsa-miR-196	mmu-miR-213
uagguaguuucauguuguugg	accaucgaccguugauuguacc
hsa-miR-197	mmu-miR-214
uucaccaccuucuccacccagc	acagcaggcacagacaggcag
hsa-miR-198	mmu-miR-216
gguccagaggggagauagg	uaaucucagcuggcaacugug
hsa-miR-199a	mmu-miR-218
cccaguguucagacuaccuguuc	uugugcuugaucuaaccaugu
hsa-miR-199a*	mmu-miR-219
uacaguagucugcacauugguu	ugauuguccaaacgcaauucu
hsa-miR-208	mmu-miR-223
auaagacgagcaaaaagcuugu	ugucaguuugucaaauacccc
hsa-miR-148a	mmu-miR-320
ucagugcacuacagaacuuugu	aaaagcuggguugagagggcgaa
hsa-miR-30c	mmu-miR-321
uguaaacauccuacacucucagc	uaagccagggauuguggguuc
hsa-miR-30d	mmu-miR-33
uguaaacauccccgacuggaag	gugcauuguaguugcauug
hsa-miR-139	mmu-miR-211
ucuacagugcacgugucu	uucccuuugucauccuuugccu
hsa-miR-147	mmu-miR-221
guguguggaaaugcuucugc	agcuacauugucugcuggguuu
hsa-miR-7	mmu-miR-222
uggaagacuagugauuuuguu	agcuacaucuggcuacugggucu
hsa-miR-10a	mmu-miR-224
uacccuguagauccgaauuugug	uaagucacuagugguuccguuua
hsa-miR-10b	mmu-miR-199b
uacccuguagaaccgaauuugu	cccaguguuuagacuaccuguuc
hsa-miR-34a	mmu-miR-181b
uggcagugucuuagcugguugu	aacauucauugcugucgguggguu
hsa-miR-181a	mmu-miR-181c
aacauucaacgcugucggugagu	aacauucaaccugucggugagu
hsa-miR-181b	mmu-miR-128b
aacauucauugcugucgguggguu	ucacagugaaccggucucuuuc
hsa-miR-181c	mmu-miR-7
aacauucaaccugucggugagu	uggaagacuagugauuuuguu
hsa-miR-182	mmu-miR-7b
uuuggcaaugguagaacucaca	uggaagacuugugauuuuguu
hsa-miR-182*	mmu-miR-217
ugguucuagacuugccaacua	uacugcaucaggaacugacuggau
hsa-miR-183	mmu-miR-133b
uauggcacugguagaauucacug	uugguccccuucaaccagcua
hsa-miR-187	mmu-miR-215
ucgugucuuguguugcagccg	augaccuaugauuugacagac
hsa-miR-199b
cccaguguuuagacuaucuguuc
hsa-miR-203	dme-miR-1
gugaaauguuuaggaccacuag	uggaauguaaagaaguauggag
hsa-miR-204	dme-miR-2a
uucccuuugucauccuaugccu	uaucacagccagcuuugaugagc
hsa-miR-205	dme-miR-2b
uccuucauuccaccggagucug	uaucacagccagcuuugaggagc
hsa-miR-210	dme-miR-3
cugugcgugugacagcggcug	ucacugggcaaagugugucuca
hsa-miR-211	dme-miR-4
uucccuuugucauccuucgccu	auaaagcuagacaaccauuga
hsa-miR-212	dme-miR-5
uaacagucuccagucacggcc	aaaggaacgaucguugugauaug
hsa-miR-213	dme-miR-6
accaucgaccguugauuguacc	uaucacaguggcuguucuuuuu
hsa-miR-214	dme-miR-7
acagcaggcacagacaggcag	uggaagacuagugauuuuguugu
hsa-miR-215	dme-miR-8
augaccuaugaauugacagac	uaauacugucagguaaagauguc
hsa-miR-216	dme-miR-9a
uaaucucagcuggcaacugug	ucuuugguuaucuagcuguauga
hsa-miR-217	dme-miR-10
uacugcaucaggaacugauuggau	acccuguagauccgaauuugu
hsa-miR-218	dme-miR-11
uugugcuugaucuaaccaugu	caucacagucugaguucuugc
hsa-miR-219	dme-miR-12
ugauuguccaaacgcaauucu	ugaguauuacaucagguacuggu
hsa-miR-220	dme-miR-13a
ccacaccguaucugacacuuu	uaucacagccauuuugaugagu
hsa-miR-221	dme-miR-13b
agcuacauugucugcuggguuuc	uaucacagccauuuugacgagu
hsa-miR-222	dme-miR-14
agcuacaucuggcuacugggucuc	ucagucuuuuucucucuccua
hsa-miR-223	dme-miR-263a
ugucaguuugucaaauacccc	guuaauggcacuggaagaauucac
hsa-miR-224	dme-miR-184*
caagucacuagugguuccguuua	ccuuaucauucucucgccccg
hsa-miR-200b	dme-miR-184
cucuaauacugccugguaaugaug	uggacggagaacugauaagggc
hsa-let-7g	dme-miR-274
ugagguaguaguuuguacagu	uuuugugaccgacacuaacggguaau
hsa-let-7i	dme-miR-275
ugagguaguaguuugugcu	ucagguaccugaaguagcgcgcg
hsa-miR-1	dme-miR-92a
uggaauguaaagaaguaugua	cauugcacuugucccggccuau
hsa-miR-15b	dme-miR-219
uagcagcacaucaugguuuaca	ugauuguccaaacgcaauucuug
hsa-miR-23b	dme-miR-276a*
aucacauugccagggauuaccac	cagcgagguauagaguuccuacg
hsa-miR-27b	dme-miR-276a
uucacaguggcuaaguucug	uaggaacuucauaccgugcucu
hsa-miR-30b	dme-miR-277
uguaaacauccuacacucagc	uaaaugcacuaucugguacgaca
hsa-miR-122a	dme-miR-278
uggagugugacaaugguguuugu	ucggugggacuuucguccguuu
hsa-miR-124a	dme-miR-133
uuaaggcacgcggugaaugcca	uugguccccuucaaccagcugu
hsa-miR-125b	dme-miR-279
ucccugagacccuaacuuguga	ugacuagauccacacucauuaa
hsa-miR-128a	dme-miR-33
ucacagugaaccggucucuuuu	aggugcauuguagucgcauug
hsa-miR-130a	dme-miR-280
cagugcaauguuaaaagggc	uguauuuacguugcauaugaaaugaua
hsa-miR-132	dme-miR-281-1*
uaacagucuacagccauggucg	aagagagcuguccgucgacagu
hsa-miR-133a	dme-miR-281
uugguccccuucaaccagcugu	ugucauggaauugcucucuuugu
hsa-miR-135a	dme-miR-282
uauggcuuuuuauuccuauguga	aaucuagccucuacuaggcuuugucugu
hsa-miR-137	dme-miR-283
uauugcuuaagaauacgcguag	uaaauaucagcugguaauucu
hsa-miR-138	dme-miR-284
agcugguguugugaauc	ugaagucagcaacuugauuccagcaauug
hsa-miR-140	dme-miR-281-2*
agugguuuuacccuaugguag	aagagagcuauccgucgacagu
hsa-miR-141	dme-miR-34
aacacugucugguaaagaugg	uggcagugugguuagcugguug
hsa-miR-142-5p	dme-miR-124
cauaaaguagaaagcacuac	uaaggcacgcggugaaugccaag
hsa-miR-142-3p	dme-miR-79
uguaguguuuccuacuuuaugga	uaaagcuagauuaccaaagcau
hsa-miR-143	dme-miR-276b*
ugagaugaagcacuguagcuca	cagcgagguauagaguuccuacg
hsa-miR-144	dme-miR-276b
uacaguauagaugauguacuag	uaggaacuuaauaccgugcucu
hsa-miR-145	dme-miR-210
guccaguuuucccaggaaucccuu	uugugcgugugacagcggcua
hsa-miR-152	dme-miR-285
ucagugcaugacagaacuugg	uagcaccauucgaaaucagugc
hsa-miR-153	dme-miR-100
uugcauagucacaaaaguga	aacccguaaauccgaacuugug
hsa-miR-191	dme-miR-92b
caacggaaucccaaaagcagcu	aauugcacuagucccggccugc
hsa-miR-9	dme-miR-286
ucuuugguuaucuagcuguauga	ugacuagaccgaacacucgugcu
hsa-miR-9*	dme-miR-287
uaaagcuagauaaccgaaagu	uguguugaaaaucguuugcac
hsa-miR-125a	dme-miR-87
ucccugagacccuuuaaccugug	uugagcaaaauuucaggugug
hsa-miR-126*	dme-miR-263b
cauuauuacuuuugguacgcg	cuuggcacugggagaauucac
hsa-miR-126	dme-miR-288
ucguaccgugaguaauaaugc	uuucaugucgauuucauuucaug
hsa-miR-127	dme-miR-289
ucggauccgucugagcuuggcu	uaaauauuuaaguggagccugcgacu
hsa-miR-129	dme-bantam
cuuuuugcggucugggcuugc	ugagaucauuuugaaagcugauu
hsa-miR-134	dme-miR-303
ugugacugguugaccagaggg	uuuagguuucacaggaaacuggu
hsa-miR-136	dme-miR-31b
acuccauuuguuuugaugaugga	uggcaagaugucggaauagcug
hsa-miR-146	dme-miR-304
ugagaacugaauuccauggguu	uaaucucaauuuguaaaugugag
hsa-miR-149	dme-miR-305
ucuggcuccgugucuucacucc	auuguacuucaucaggugcucug
hsa-miR-150	dme-miR-9c
ucucccaacccuuguaccagug	ucuuugguauucuagcuguaga
hsa-miR-154	dme-miR-306
uagguuauccguguugccuucg	ucagguacuuagugacucucaa
hsa-miR-184	dme-miR-306*
uggacggagaacugauaagggu	gggggucacucugugccugugc
hsa-miR-185	dme-miR-9b
uggagagaaaggcaguuc	ucuuuggugauuuuagcuguaug
hsa-miR-186	dme-let-7
caaagaauucuccuuuugggcuu	ugagguaguagguuguauagu
hsa-miR-188	dme-miR-125
caucccuugcaugguggagggu	ucccugagacccuaacuuguga
hsa-miR-190	dme-miR-307
ugauauguuugauauauuaggu	ucacaaccuccuugagugag
hsa-miR-193	dme-miR-308
aacuggccuacaaagucccag	aaucacaggauuauacugugag
hsa-miR-194	dme-miR-31a
uguaacagcaacuccaugugga	uggcaagaugucggcauagcuga
hsa-miR-195	dme-miR-309
uagcagcacagaaauauuggc	gcacuggguaaaguuuguccua
hsa-miR-206	dme-miR-310
uggaauguaaggaagugugugg	uauugcacacuucccggccuuu
hsa-miR-320	dme-miR-311
aaaagcuggguugagagggcgaa	uauugcacauucaccggccuga
hsa-miR-321	dme-miR-312
uaagccagggauuguggguuc	uauugcacuugagacggccuga
hsa-miR-200c	dme-miR-313
aauacugccggguaaugaugga	uauugcacuuuucacagcccga
hsa-miR-155	dme-miR-314
uuaaugcuaaucgugauagggg	uauucgagccaauaaguucgg
hsa-miR-128b	dme-miR-315
ucacagugaaccggucucuuuc	uuuugauuguugcucagaaagc
hsa-miR-106b	dme-miR-316
uaaagugcugacagugcagau	ugucuuuuuccgcuuacuggcg
hsa-miR-29c	dme-miR-317
uagcaccauuugaaaucgguua	ugaacacagcuggugguauccagu
hsa-miR-200a	dme-miR-318
uaacacugucugguaacgaugu	ucacugggcuuuguuuaucuca
hsa-miR-302	dme-miR-2c
uaagugcuuccauguuuugguga	uaucacagccagcuuugaugggc
hsa-miR-34b	dme-miR-iab-4-5p
aggcagugucauuagcugauug	acguauacugaauguauccuga
hsa-miR-34c	dme-miR-iab-4-3p
aggcaguguaguuagcugauug	cgguauaccuucaguauacguaac
hsa-miR-299
ugguuuaccgucccacauacau
hsa-miR-301	mo-miR-322
cagugcaauaguauugucaaagc	aaacaugaagcgcugcaaca
hsa-miR-99b	mo-miR-323
cacccguagaaccgaccuugcg	gcacauuacacggucgaccucu
hsa-miR-296	mo-miR-301
agggcccccccucaauccugu	cagugcaauaguauugucaaagcau
hsa-miR-130b	mo-miR-324-5p
cagugcaaugaugaaagggcau	cgcauccccuagggcauuggugu
hsa-miR-30e	mo-miR-324-3p
uguaaacauccuugacugga	ccacugccccaggugcugcugg
hsa-miR-340	mo-miR-325
uccgucucaguuacuuuauagcc	ccuaguaggugcucaguaagugu
hsa-miR-330	mo-miR-326
gcaaagcacacggccugcagaga	ccucugggcccuuccuccagu
hsa-miR-328	mno-let-7d
cuggcccucucugcccuuccgu	agagguaguagguugcauagu
hsa-miR-342	mo-let-7d*
ucucacacagaaaucgcacccguc	cuauacgaccugcugccuuucu
hsa-miR-337	mo-miR-328
uccagcuccuauaugaugccuuu	cuggcccucucugcccuuccgu
hsa-miR-323	mo-miR-329
gcacauuacacggucgaccucu	aacacacccagcuaaccuuuuu
hsa-miR-326	mo-miR-330
ccucugggcccuuccuccag	gcaaagcacagggccugcagaga
hsa-miR-151	mo-miR-331
acuagacugaagcuccuugagg	gccccugggccuauccuagaa
hsa-miR-135b	mo-miR-333
uauggcuuuucauuccuaugug	guggugugcuaguuacuuuu
hsa-miR-148b	mo-miR-140
ucagugcaucacagaacuuugu	agugguuuuacccuaugguag
hsa-miR-331	mo-miR-140*
gccccugggccuauccuagaa	uaccacaggguagaaccacggaca
hsa-miR-324-5p	mo-miR-336
cgcauccccuagggcauuggugu	ucacccuuccauaucuagucu
hsa-miR-324-3p	mo-miR-337
ccacugccccaggugcugcugg	uucagcuccuauaugaugccuuu
hsa-miR-338	mo-miR-148b
uccagcaucagugauuuuguuga	ucagugcaucacagaacuuugu
hsa-miR-339	mo-miR-338
ucccuguccuccaggagcuca	uccagcaucagugauuuuguuga
hsa-miR-335	mo-miR-339
ucaagagcaauaacgaaaaaugu	ucccuguccuccaggagcuca
hsa-miR-133b	mo-miR-341
uugguccccuucaaccagcua	ucgaucggucggucggucagu
	mo-miR-342
	ucucacacagaaaucgcacccguc
osa-miR156	mo-miR-344
ugacagaagagagugagcac	ugaucuagccaaagccugaccgu
osa-miR160	mo-miR-345
ugccuggcucccuguaugcca	ugcugaccccuaguccagugc
osa-miR162	mo-miR-346
ucgauaaaccucugcauccag	ugucugccugagugccugccucu
osa-miR164	mo-miR-349
uggagaagcagggcacgugca	cagcccugcugucuuaaccucu
osa-miR166	mo-miR-129
ucggaccaggcuucauucccc	cuuuuugcggucugggcuugcu
osa-miR167	mo-miR-129*
ugaagcugccagcaugaucua	aagcccuuaccccaaaaagcau
osa-miR169	mo-miR-20
cagccaaggaugacuugccga	uaaagugcuuauagugcagguag
osa-miR171	mo-miR-20*
ugauugagccgcgccaauauc	acugcauuacgagcacuuaca
	mo-miR-350
	uucacaaagcccauacacuuucac
	mo-miR-7
	uggaagacuagugauuuuguu
	mo-miR-7*
	caacaaaucacagucugccaua
	mo-miR-351
	ucccugaggagcccuuugagccug
	mo-miR-135b
	uauggcuuuucauuccuaugug
	mo-miR-151*
	ucgaggagcucacagucuagua
	mo-miR-151
	acuagacugaggcuccuugagg
	mo-miR-101b
	uacaguacugugauagcugaag
	mo-let-7a
	ugagguaguagguuguauaguu
	mo-let-7b
	ugagguaguagguugugugguu
	mo-let-7c
	ugagguaguagguuguaugguu
	mo-let-7e
	ugagguaggagguuguauagu
	mo-let-7f
	ugagguaguagauuguauaguu
	mo-let-7i
	ugagguaguaguuugugcu
	mo-miR-7b
	uggaagacuugugauuuuguu
	mo-miR-9
	ucuuugguuaucuagcuguauga
	mo-miR-10a
	uacccuguagauccgaauuugug
	mo-miR-10b
	uacccuguagaaccgaauuugu
	mo-miR-15b
	uagcagcacaucaugguuuaca
	mo-miR-16
	uagcagcacguaaauauuggcg
	mo-miR-17
	caaagugcuuacagugcagguagu
	mo-miR-18
	uaaggugcaucuagugcagaua
	mo-miR-19b
	ugugcaaauccaugcaaaacuga
	mo-miR-19a
	ugugcaaaucuaugcaaaacuga
	mo-miR-21
	uagcuuaucagacugauguuga
	mo-miR-22
	aagcugccaguugaagaacugu
	mo-miR-23a
	aucacauugccagggauuucc
	mo-miR-23b
	aucacauugccagggauuaccac
	mo-miR-24
	uggcucaguucagcaggaacag
	mo-miR-25
	cauugcacuugucucggucuga
	mo-miR-26a
	uucaaguaauccaggauaggcu
	mo-miR-26b
	uucaaguaauucaggauagguu
	mo-miR-27b
	uucacaguggcuaaguucug
	mo-miR-27a
	uucacaguggcuaaguuccgc
	mo-miR-28
	aaggagcucacagucuauugag
	mo-miR-29b
	uagcaccauuugaaaucagugu
	mo-miR-29a
	cuagcaccaucugaaaucgguu
	mo-miR-29c
	uagcaccauuugaaaucgguua
	mo-miR-30c
	uguaaacauccuacacucucagc
	mo-miR-30e
	uguaaacauccuugacugga
	mo-miR-30b
	uguaaacauccuacacucagc
	mo-miR-30d
	uguaaacauccccgacuggaag
	mo-miR-30a
	cuuucagucggauguuugcagc
	mo-miR-31
	aggcaagaugcuggcauagcug
	mo-miR-32
	uauugcacauuacuaaguugc
	mo-miR-33
	gugcauuguaguugcauug
	mo-miR-34b
	uaggcaguguaauuagcugauug
	mo-miR-34c
	aggcaguguaguuagcugauugc
	mo-miR-34a
	uggcagugucuuagcugguuguu
	mo-miR-92
	uauugcacuugucccggccug
	mo-miR-93
	caaagugcuguucgugcagguag
	mo-miR-96
	uuuggcacuagcacauuuuugcu
	mo-miR-98
	ugagguaguaaguuguauuguu
	mo-miR-99a
	aacccguagauccgaucuugug
	mo-miR-99b
	cacccguagaaccgaccuugcg
	mo-miR-100
	aacccguagauccgaacuugug
	mo-miR-101
	uacaguacugugauaacugaag
	mo-miR-103
	agcagcauuguacagggcuauga
	mo-miR-106b
	uaaagugcugacagugcagau
	mo-miR-107
	agcagcauuguacagggcuauca
	mo-miR-122a
	uggagugugacaaugguguuugu
	mo-miR-124a
	uuaaggcacgcggugaaugcca
	mo-miR-125a
	ucccugagacccuuuaaccugug
	mo-miR-125b
	ucccugagacccuaacuuguga
	mo-miR-126*
	cauuauuacuuuugguacgcg
	mo-miR-126
	ucguaccgugaguaauaaugc
	mo-miR-127
	ucggauccgucugagcuuggcu
	mo-miR-128a
	ucacagugaaccggucucuuuu
	mo-miR-128b
	ucacagugaaccggucucuuuc
	mo-miR-130a
	cagugcaauguuaaaagggc
	mo-miR-130b
	cagugcaaugaugaaagggcau
	mo-miR-132
	uaacagucuacagccauggucg
	mo-miR-133a
	uugguccccuucaaccagcugu
	mo-miR-134
	ugugacugguugaccagaggg
	mo-miR-135a
	uauggcuuuuuauuccuauguga
	mo-miR-136
	acuccauuuguuuugaugaugga
	mo-miR-137
	uauugcuuaagaauacgcguag
	mo-miR-138
	agcugguguugugaauc
	mo-miR-139
	ucuacagugcacgugucu
	mo-miR-141
	aacacugucugguaaagaugg
	mo-miR-142-5p
	cauaaaguagaaagcacuac
	mo-miR-142-3p
	uguaguguuuccuacuuuaugga
	mo-miR-143
	ugagaugaagcacuguagcuca
	mo-miR-144
	uacaguauagaugauguacuag
	mo-miR-145
	guccaguuuucccaggaaucccuu
	mo-miR-146
	ugagaacugaauuccauggguu
	mo-miR-150
	ucucccaacccuuguaccagug
	mo-miR-152
	ucagugcaugacagaacuugg
	mo-miR-153
	uugcauagucacaaaaguga
	mo-miR-154
	uagguuauccguguugccuucg
	mo-miR-181c
	aacauucaaccugucggugagu
	mo-miR-181a
	aacauucaacgcugucggugagu
	mo-miR-181b
	aacauucauugcugucgguggguu
	mo-miR-183
	uauggcacugguagaauucacug
	mo-miR-184
	uggacggagaacugauaagggu
	mo-miR-185
	uggagagaaaggcaguuc
	mo-miR-186
	caaagaauucuccuuuugggcuu
	mo-miR-187
	ucgugucuuguguugcagccg
	mo-miR-190
	ugauauguuugauauauuaggu
	mo-miR-191
	caacggaaucccaaaagcagcu
	mo-miR-192
	cugaccuaugaauugacagcc
	mo-miR-193
	aacuggccuacaaagucccag
	mo-miR-194
	uguaacagcaacuccaugugga
	mo-miR-195
	uagcagcacagaaauauuggc
	mo-miR-196
	uagguaguuucauguuguugg
	mo-miR-199a
	cccaguguucagacuaccuguuc
	mo-miR-200c
	aauacugccggguaaugaugga
	mo-miR-200a
	uaacacugucugguaacgaugu
	mo-miR-200b
	cucuaauacugccugguaaugaug
	mo-miR-203
	gugaaauguuuaggaccacuag
	mo-miR-204
	uucccuuugucauccuaugccu
	mo-miR-205
	uccuucauuccaccggagucug
	mo-miR-206
	uggaauguaaggaagugugugg
	mo-miR-208
	auaagacgagcaaaaagcuugu
	mo-miR-210
	cugugcgugugacagcggcug
	mo-miR-211
	uucccuuugucauccuuugccu
	mo-miR-212
	uaacagucuccagucacggcc
	mo-miR-213
	accaucgaccguugauuguacc
	mo-miR-214
	acagcaggcacagacaggcag
	mo-miR-216
	uaaucucagcuggcaacugug
	mo-miR-217
	uacugcaucaggaacugacuggau
	mo-miR-218
	uugugcuugaucuaaccaugu
	mo-miR-219
	ugauuguccaaacgcaauucu
	mo-miR-221
	agcuacauugucugcuggguuuc
	mo-miR-222
	agcuacaucuggcuacugggucuc
	mo-miR-223
	ugucaguuugucaaauacccc
	mo-miR-290
	cucaaacuaugggggcacuuuuu
	mo-miR-291-5p
	caucaaaguggaggcccucucu
	mo-miR-291-3p
	aaagugcuuccacuuugugugcc
	mo-miR-292-5p
	acucaaacugggggcucuuuug
	mo-miR-292-3p
	aagugccgccagguuuugagugu
	mo-miR-296
	agggcccccccucaauccugu
	mo-miR-297
	auguaugugugcauguaugcaug
	mo-miR-298
	ggcagaggagggcuguucuucc
	mo-miR-299
	ugguuuaccgucccacauacau
	mo-miR-300
	uaugcaagggcaagcucucuuc
	mo-miR-320
	aaaagcuggguugagagggcgaa
	mo-miR-321
	uaagccagggauuguggguuc

[0090] Although the disclosed teachings have been described with reference to various applications, methods, kits, and compositions, it will be appreciated that various changes and modifications may be made without departing from the teachings herein. The foregoing examples are provided to better illustrate the disclosed teachings and are not intended to limit the scope of the teachings herein.